Processing 00000000.tx.1: Primary Cultured Neurons Devoid of Cellular Prion Display Lower Responsiveness to Staurosporine through the Control of p53 at Both Transcriptional and Post-transcriptional Levels* Erwan Paitel, Claire Sunyach, Cristine Alves da Costa, Jean-Christophe Bourdon, Bruno Vincent, and Frdric Checler|| From the Institut de Pharmacologie Molculaire et Cellulaire du CNRS, UMR6097, 06560 Valbonne, France and Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, United Kingdom Received for publication, September 22, 2003  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  We assessed the contribution of the cellular prion protein (PrPc) in the control of neuronal apoptosis by examining cell death in both human cells and murine primary cultured neurons. 

Phrase: "Primary Cultured Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "Devoid of Cellular Prion Display Lower Responsiveness"

Phrase: "to Staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "through the Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "at Both Transcriptional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcriptional [Genetic Function]

Phrase: "and"

Phrase: "Post-transcriptional Levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "* Erwan Paitel,"

Phrase: "Claire Sunyach,"

Phrase: "Cristine Alves da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0035561:Costa [Body Part, Organ, or Organ Component]
   719 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "Jean-Christophe Bourdon,"

Phrase: "Bruno Vincent,"

Phrase: "and"

Phrase: "Frdric Checler||"

Phrase: "From the Institut de Pharmacologie Molculaire et Cellulaire du CNRS,"

Phrase: "UMR6097,"

Phrase: "06560 Valbonne,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "and"

Phrase: "Ninewells Hospital"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "and"

Phrase: "Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   861   C0036375:School [Manufactured Object,Organization]

Phrase: "Dundee DD1 9SY,"

Phrase: "Scotland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036453:Scotland [Geographic Area]

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "September 22,"

Phrase: "2003  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the contribution of the cellular prion protein (PrPc)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "in the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of neuronal apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1660771:neuron apoptosis [Cell Function]
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "by examining cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "in both human cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "murine primary cultured neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.2: We first confirmed our previous finding that staurosporine-induced caspase activation is increased by PrPc overexpression in HEK293 cells. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "our previous finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "that staurosporine-induced caspase activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1159825:Caspase Activation [Molecular Function]
   812   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "increased by PrPc overexpression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   806   C1418941:PRION PROTEIN [Gene or Genome]
   806   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "in HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.3: We show here that this phenotype is fully dependent on p53 and that the control of p53 activity by PrPc occurs at both transcriptional and post-transcriptional levels in human cells. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that"

Phrase: "this phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "fully dependent on p53"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the control of p53 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1706449:Active Control [Research Activity]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "by PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "occurs at both transcriptional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0040649:Transcriptional [Genetic Function]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "post-transcriptional levels in human cells."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.4: Of most interest, we demonstrate that neuronal endogenous PrPc also controls a p53-dependent pro-apoptotic phenotype. 

Phrase: "Of most interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that neuronal endogenous PrPc also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   840   C1418941:PRION PROTEIN [Gene or Genome]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "a p53-dependent pro-apoptotic phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031437:Phenotype [Organism Attribute]
   804   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.5: Thus, DNA fragmentation and TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling)-positive cells were lower in primary cultured neurons derived from Zrch-1 mice embryos in which PrPc has been abrogated than in wild-type neurons. 

Phrase: "Thus,"

Phrase: "DNA fragmentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "and"

Phrase: "TUNEL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600528:TUNEL [Molecular Biology Research Technique]

Phrase: "(terminal deoxynucleotidyltransferase-mediated dUTP nick end-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0444930:End [Spatial Concept]
   799   C2746065:End [Temporal Concept]

Phrase: "labeling"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]
   966 E C0181496:Label [Manufactured Object]

Phrase: ")-"

Phrase: "positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0439178:% positive cells [Quantitative Concept]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lower in primary cultured neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "derived from Zrch-1 mice embryos"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0013935:Embryos [Embryonic Structure]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]
   719 E C1305370:Embryo [Embryonic Structure]

Phrase: "in which PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "abrogated than"

Phrase: "in wild-type neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.6: PrPc knock-out neurons also displayed drastically diminished caspase-3-like activity and immunoreactivity together with reduced p53 expression and transcriptional activity, a phenotype complemented in part by PrPc transfection. 

Phrase: "PrPc knock-out neurons also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "drastically diminished caspase-3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "immunoreactivity together with reduced p53 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "transcriptional activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "a phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "complemented in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]
   756   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by PrPc transfection."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   734   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
   734   C1418941:PRION PROTEIN [Gene or Genome]
Processing 00000000.tx.7: Interestingly, p53 expression was also reduced in the brain of adult Prnp-/- mice. 

Phrase: "Interestingly,"

Phrase: "p53 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "reduced in the brain of adult Prnp-/- mice."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   750   C1521713:Mouse Brain [Tissue]
   744   C0001675:Adult [Age Group]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0392756:Reduced [Qualitative Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1418941:PRNP [Gene or Genome]
   744   C1706450:Adult [Human]
Processing 00000000.tx.8: Neuronal PrPc likely controls p53 at a post-transcriptional level because the deletion of cellular prion protein is accompanied by a higher Mdm2-like immunoreactivity and reduced phosphorylated p38 MAPK expression. 

Phrase: "Neuronal PrPc likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   861   C1418941:PRION PROTEIN [Gene or Genome]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "p53 at a post-transcriptional level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079419:P53 [Gene or Genome]
   753   C1705526:p53 [Gene or Genome]

Phrase: "because"

Phrase: "the deletion of cellular prion protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "is"

Phrase: "accompanied by a higher Mdm2-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0812222:MDM2 [Gene or Genome]
   760   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "phosphorylated p38 MAPK expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.9: We therefore propose that the physiological function of endogenous cellular prion could be to regulate p53-dependent caspase-3-mediated neuronal cell death. 

Phrase: "We therefore"

Phrase: "propose"

Phrase: "that"

Phrase: "the physiological function of endogenous cellular prion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0007613:Cellular Function [Cell Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "p53-dependent caspase-3-mediated neuronal cell death."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   835   C2754100:neuronal cell death [Cell Function]
           neuron death
   812   C0007587:Cell Death [Cell Function]
   793   C0007634:Cell [Cell]
   793   C0011065:Death [Organism Function]
   793   C1269647:Cell [Cell]
   793   C1306577:Death, NOS [Finding]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.10: This phenotype likely occurs through up-regulation of p53 promoter transactivation as well as downstream by controlling p53 stability via Mdm2 expression.  

Phrase: "This phenotype likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "occurs through up-regulation of p53 promoter transactivation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0040624:Transactivation [Genetic Function]
   744   C0079419:P53 [Gene or Genome]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C1705526:p53 [Gene or Genome]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]

Phrase: "as well as"

Phrase: "downstream by controlling p53 stability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522506:Downstream [Spatial Concept]

Phrase: "via Mdm2 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Prion-related pathologies are now better understood as diseases that can be of either sporadic or infectious origin but always have a fatal outcome (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Prion-related pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0030664:Pathologies [Biomedical Occupation or Discipline]
   793 E C0205469:pathology [Functional Concept]
   793 E C0677042:pathology [Pathologic Function]
   743 E C1521733:Pathologic [Functional Concept]

Phrase: "are"

Phrase: "now better understood as diseases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0332272:Better [Qualitative Concept]
   726   C0162340:Understand [Mental Process]
   726 E C0205170:Well [Qualitative Concept]
   726 E C3146287:Well [Manufactured Object]

Phrase: "that"

Phrase: "can"

Phrase: "be of either sporadic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205422:Sporadic [Temporal Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "or"

Phrase: "infectious origin"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   861   C0079946:origin [Classification]
   861   C0439659:Origin [Temporal Concept]
   861   C1550512:origin [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   789 E C0205313:Original [Idea or Concept]
   789 E C2347409:Original [Occupational Activity]
   777 E C0005615:Birth [Organism Function]
   777 E C0035150:Reproduction [Organism Function]
   777 E C1550722:birth [Idea or Concept]
   777 E C3245487:birth [Intellectual Product]
   761 E C0454729:Natal [Geographic Area]
   761 E C0559522:Genital [Body System]
   761 E C0598240:originality [Mental Process]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]

Phrase: "but"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "have"

Phrase: "a fatal outcome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206277:Fatal Outcome [Pathologic Function]
   861   C1274040:Outcome [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: These pathologies are not conventional, first because they appear to be caused mainly by a unique protein that bears the potential of transmissibility in infectious cases of these diseases. 

Phrase: "These pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0030664:Pathologies [Biomedical Occupation or Discipline]
   966 E C0205469:pathology [Functional Concept]
   966 E C0677042:pathology [Pathologic Function]
   916 E C1521733:Pathologic [Functional Concept]

Phrase: "are"

Phrase: "not conventional, first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205435:First [Quantitative Concept]
   827   C1279901:First [Qualitative Concept]

Phrase: "because"

Phrase: "they"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "mainly by a unique protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1710548:Unique [Qualitative Concept]

Phrase: "that"

Phrase: "bears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "the potential of transmissibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3245505:Potential [Qualitative Concept]

Phrase: "in infectious cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "of these diseases."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.13: It is now widely admitted that transmission occurs independently of any accompanying nucleic acid or viral particles (1, 3). 

Phrase: "It"

Phrase: "is"

Phrase: "now widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948052:Now [Temporal Concept]

Phrase: "admitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184666:admitted [Health Care Activity]

Phrase: "that transmission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040722:transmission [Idea or Concept]
  1000   C0242781:Transmission [Pathologic Function]
  1000   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "occurs independently of any"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "accompanying"

Phrase: "nucleic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028606:Nucleic acid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001128:Acid [Chemical]
   861   C0007610:Nucleic [Cell Component]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "viral particles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042760:Viral Particles [Cell Component]
  1000   C1883540:Viral Particles [Quantitative Concept]
   861   C0521026:Viral [Functional Concept]
   861   C0597177:particles [Chemical Viewed Structurally]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Second, and of most interest, was the demonstration that the scrapie (also called PrPres)1 is the highly protease-resistant conformer of a ubiquitous protein counterpart referred to as cellular prion protein (PrPc) (4, 5). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and of most interest,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543488:Interest [Mental Process]
   770   C1515981:And [Idea or Concept]

Phrase: "was"

Phrase: "the demonstration"

Phrase: "that"

Phrase: "the scrapie"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036457:Scrapie [Disease or Syndrome]

Phrase: "(also called PrPres"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074204:PrP-res [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "is"

Phrase: "the highly protease-resistant conformer of a ubiquitous protein counterpart"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0180093:Conformer [Medical Device]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "cellular prion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.15: Another striking aspect is that the host PrPc seems to act as a "substratum" for scrapie as demonstrated by the fact that in animals deficient in endogenous PrPc, highly infectious "scrapie-rich" inoculates fail to transmit the disease (6, 7). 

Phrase: "Another striking aspect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1547011:Aspect [Quantitative Concept]
   861   C1879746:Aspect [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the host PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as a ""substratum"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "for scrapie"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036457:Scrapie [Disease or Syndrome]

Phrase: "as"

Phrase: "demonstrated by the fact"

Phrase: "that in animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003062:Animals [Animal]

Phrase: "deficient in endogenous PrPc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011155:Deficient [Functional Concept]
   760   C1636779:% deficient [Quantitative Concept]

Phrase: "highly infectious ""scrapie-rich"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0699759:Rich [Qualitative Concept]

Phrase: "inoculates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987620:Inoculate [Therapeutic or Preventive Procedure]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transmit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332289:transmit [Functional Concept]

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.16: This observation is not fully understood at a molecular level, and the mechanisms by which PrPc is converted into scrapie remain a matter of speculation. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood at a molecular level,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
   726   C0162340:Understand [Mental Process]

Phrase: "and"

Phrase: "the mechanisms by which PrPc"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "converted into scrapie"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036457:Scrapie [Disease or Syndrome]

Phrase: "remain"

Phrase: "a matter of speculation."
Processing 00000000.tx.17: Furthermore, this does not explain most of the sporadic cases that are characterized at late stages by spontaneous deposition of PrPres in the absence of exogenous "pathogenic" species. 

Phrase: "Furthermore,"

Phrase: "this"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "most of the sporadic cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205393:Most [Quantitative Concept]
   760   C0205422:Sporadic [Temporal Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "characterized at late stages"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C1279941:late stages [Temporal Concept]
   770   C0205087:Late [Temporal Concept]
   770   C1306673:Stages [Qualitative Concept]
   770   C1880022:Characterized [Activity]
   737 E C0205390:Stage [Temporal Concept]
   737 E C1300072:Stage [Clinical Attribute]

Phrase: "by spontaneous deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "of PrPres"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074204:PrP-res [Amino Acid, Peptide, or Protein]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of exogenous ""pathogenic"" species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.18: Some clues to further understand PrP-related pathologies might come from a better knowledge of PrPc physiology and putative dysfunctions responsible for the disease. 

Phrase: "Some clues to further"

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "PrP-related pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0030664:Pathologies [Biomedical Occupation or Discipline]
   793 E C0205469:pathology [Functional Concept]
   793 E C0677042:pathology [Pathologic Function]
   743 E C1521733:Pathologic [Functional Concept]

Phrase: "might"

Phrase: "come from a better knowledge of PrPc physiology"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   764   C1418941:PRION PROTEIN [Gene or Genome]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0031842:Physiology [Biomedical Occupation or Discipline]
   742   C0031843:physiology [Physiologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332272:Better [Qualitative Concept]
   742   C0376554:Knowledge [Intellectual Product]

Phrase: "and"

Phrase: "putative dysfunctions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   789 E C0231174:Malfunction [Functional Concept]
   789 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "responsible for the disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.19: In this respect, an interesting discussion revolving around cell death is ongoing, opening a new field of investigation. 

Phrase: "In this respect,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679133:respect [Social Behavior]

Phrase: "an interesting discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: "revolving around cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "ongoing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:ONGOING [Idea or Concept]

Phrase: "opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175566:Opening [Spatial Concept]
  1000   C1882151:Opening [Spatial Concept]

Phrase: "a new field of investigation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   760   C1521738:Field [Conceptual Entity]
   760   C2346620:Field [Conceptual Entity]
   760   C2349184:Field [Conceptual Entity]
   760   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.20: It is clear that apoptosis accompanies the late stages of the disease. 

Phrase: "It"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "accompanies"

Phrase: "the late stages of the disease."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   803   C0683337:late disease stage [Finding]
   790   C1279941:late stages [Temporal Concept]
   783   C0699749:disease stages [Diagnostic Procedure]
   753   C1306673:Stages [Qualitative Concept]
   719 E C0205390:Stage [Temporal Concept]
   719 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.21: Following that idea, several groups have set out to investigate the putative role of PrPc in the control of cell death. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "that idea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "several groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "have"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the putative role of PrPc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.22: From a theoretical point of view, PrP could be antiapoptotic, and the disease could result in the abolition of this function. 

Phrase: "From a theoretical point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "of view,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "PrP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032027:PRP [Disease or Syndrome]

Phrase: "could"

Phrase: "be"

Phrase: "antiapoptotic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986514:antiapoptotic [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "could"

Phrase: "result in the abolition of this function."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1705273:Function [Intellectual Product]
   748   C2825142:Result [Finding]
Processing 00000000.tx.23: Alternatively, PrPc-related pathologies could be due to the exacerbation of a proapoptotic physiological phenotype associated with PrPc. 

Phrase: "Alternatively,"

Phrase: "PrPc-related pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0030664:Pathologies [Biomedical Occupation or Discipline]
   779 E C0205469:pathology [Functional Concept]
   779 E C0677042:pathology [Pathologic Function]
   729 E C1521733:Pathologic [Functional Concept]

Phrase: "could"

Phrase: "be due to the exacerbation of a proapoptotic physiological phenotype"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0678226:Due to [Functional Concept]
           due
   739   C0031437:Phenotype [Organism Attribute]
   739   C0205463:Physiological [Functional Concept]
   739   C1285572:Phenotype [Laboratory Procedure]
   739   C2987476:Be [Conceptual Entity]
   739   C3146286:Due [Idea or Concept]

Phrase: "associated with PrPc."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1418941:PRION PROTEIN [Gene or Genome]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.24: Studies carried out on distinct cell types, with various methodologies and approaches, have led to somewhat opposite conclusions (8-12). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on distinct cell types,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0449475:Cell types [Intellectual Product]
   773 E C0007634:Cell Type [Cell]
           Cell
   760   C0332307:Types [Qualitative Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "with various methodologies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0969625:methodology [Intellectual Product]
   827   C3266812:Methodology [Idea or Concept]

Phrase: "and"

Phrase: "approaches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approaches [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "have"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to somewhat opposite conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707478:Conclusions [Idea or Concept]

Phrase: "(8-12"

Phrase: ")."
Processing 00000000.tx.25: Our previous studies have shown that overexpression of PrPc in human embryonic kidney cells (HEK293) and TSM1 neurons as well as in an inducible cell line (Rov9) leads to increased susceptibility to apoptotic stimuli, reflected mainly by enhanced caspase-3 activity (13, 14). 

Phrase: "Our previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that overexpression of PrPc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in human embryonic kidney cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(HEK293"

Phrase: ")"

Phrase: "and"

Phrase: "TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as well as in an inducible cell line"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0007600:Cell Line [Cell]
   744   C0007634:Cell [Cell]
   744   C0205132:Line [Spatial Concept]
   744   C0205170:Well [Qualitative Concept]
   744   C0205263:Inducible [Functional Concept]
   744   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1269647:Cell [Cell]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C3146287:Well [Manufactured Object]

Phrase: "(Rov9"

Phrase: ")"

Phrase: "leads to increased susceptibility"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   819   C0861064:increased lead [Finding]
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0205217:Increased [Quantitative Concept]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C0442805:Increased [Functional Concept]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to apoptotic stimuli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "mainly by enhanced caspase-3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1150132:caspase-3 activity [Molecular Function]
   790   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   783   C1150130:caspase activity [Molecular Function]
   783   C1707919:Enhanced Activity [Quantitative Concept]
   753   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
   753   C2349975:Enhanced [Activity]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.26: We further demonstrated that in TSM1 neurons, PrPc-induced caspase-3 activation is associated with an up-regulation of p53 expression and transcriptional activity (14). 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "demonstrated"

Phrase: "that in TSM1 neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "PrPc-induced caspase-3 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   876   C0599177:protein activation [Genetic Function]
   839   C1159825:Caspase Activation [Molecular Function]
   799   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "associated with an up-regulation of p53 expression"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0079419:P53 [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C1705526:p53 [Gene or Genome]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.27: This appears to be due to Mdm2-related post-transcriptional modification of p53 (14). 

Phrase: "This"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to Mdm2-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0812222:MDM2 [Gene or Genome]
   770   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "post-transcriptional modification of p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.28: In the present study, we first establish that in HEK293, PrPc-related increased cell death is fully dependent on p53 activity. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that in HEK293,"

Phrase: "PrPc-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "increased cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "fully dependent on p53 activity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.29: Moreover, we demonstrate that p53 deletion in fibroblasts fully abolishes both PrPc-induced caspase-3 and p53 transcriptional activities. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that p53 deletion in fibroblasts fully"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "abolishes"

Phrase: "both PrPc-induced caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p53 transcriptional activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.30: We also show that in addition to our previously described post-transcriptional control of p53 (14), PrPc also enhances the transactivation of the p53 promoter. 

Phrase: "We also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in addition to our previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "post-transcriptional control of p53"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1514248:Post-Transcriptional Control [Genetic Function]
   806   C1158770:Transcriptional Control [Genetic Function]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "PrPc also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the transactivation of the p53 promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040624:Transactivation [Genetic Function]
Processing 00000000.tx.31: Because our TSM1 neurons stably overexpressed PrPc, it was also important to confirm the p53-dependent function of endogenous PrPc. 

Phrase: "Because"

Phrase: "our TSM1 neurons stably overexpressed PrPc,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   827   C1418941:PRION PROTEIN [Gene or Genome]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "it"

Phrase: "was"

Phrase: "also important to"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the p53-dependent function of endogenous PrPc."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]
Processing 00000000.tx.32: We therefore examined the physiological contribution of cellular PrPc to the control of neuronal cell death by comparing primary cultured neurons derived from mice harboring (Prnp+/+) or devoid (Prnp-/-, Zrch-1 mice (15)) of endogenous PrPc. 

Phrase: "We therefore"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the physiological contribution of cellular PrPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "to the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of neuronal cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2754100:neuronal cell death [Cell Function]
           neuron death
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "by comparing primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "derived from mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "(Prnp+/+)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418941:PRNP [Gene or Genome]

Phrase: "or"

Phrase: "devoid"

Phrase: "(Prnp-/-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418941:PRNP [Gene or Genome]

Phrase: "Zrch-1 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(15"

Phrase: ")"

Phrase: ")"

Phrase: "of endogenous PrPc."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.33: We show that neurons derived from Zrch-1 mice embryos are less sensitive to staurosporine and display lower DNA fragmentation, caspase-3 and p53 activities and expression, and higher Mdm2-like immunoreactivity. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "derived from Zrch-1 mice embryos"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0013935:Embryos [Embryonic Structure]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]
   719 E C1305370:Embryo [Embryonic Structure]

Phrase: "are"

Phrase: "less sensitive to staurosporine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "lower DNA fragmentation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0376669:DNA Fragmentation [Molecular Function]
   827   C0332472:Fragmentation [Anatomical Abnormality]
   827   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p53 activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "higher Mdm2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812222:MDM2 [Gene or Genome]
   861   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.34: We demonstrate that endogenous PrPc controls neuronal cell death via Mdm2-regulated p53-dependent caspase-3 activation in non-immortalized neurons.  

Phrase: "We"

Phrase: "demonstrate"

Phrase: "that endogenous PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "neuronal cell death via Mdm2-regulated p53-dependent caspase-3 activation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   775   C2754100:neuronal cell death [Cell Function]
           neuron death
   772   C3546446:regulated cell death [Cell Function]
   756   C0007587:Cell Death [Cell Function]
   754   C1326120:cell activation [Cell Function]
   738   C0007634:Cell [Cell]
   738   C0011065:Death [Organism Function]
   738   C1269647:Cell [Cell]
   738   C1306577:Death, NOS [Finding]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]

Phrase: "in non-immortalized neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.35: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Primary Cultured Neurons, 3F4-HEK293 Cells, and p53-deficient FibroblastsPrimary cultured neurons were prepared from the cerebral hemispheres of 14-day-old PrPc+/+ or PrPc-/-mouse embryos as described (16). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Primary Cultured Neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "3F4-HEK293 Cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "p53-deficient FibroblastsPrimary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "prepared from the cerebral hemispheres"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0228174:Cerebral Hemispheres [Body Part, Organ, or Organ Component]
   806   C1707523:Cerebral Hemispheres [Tissue]
   773 E C0007783:Cerebral hemisphere [Body Part, Organ, or Organ Component]
   726   C1521827:Prepare [Functional Concept]

Phrase: "of 14-day-old PrPc+/+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   840   C1418941:PRION PROTEIN [Gene or Genome]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "PrPc-/-mouse embryos as described"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   820   C1568447:prion protein, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0920499:embryo protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0013935:Embryos [Embryonic Structure]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   719 E C1305370:Embryo [Embryonic Structure]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.36: Briefly, cells were mechanically dissociated with a pipette in Ham's F12 medium (Invitrogen) supplemented with 10% fetal calf serum and 0.6% glucose. 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "mechanically"

Phrase: "dissociated with a pipette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0182301:Pipette [Medical Device]
   770   C1706407:Pipette [Medical Device]

Phrase: "in Ham's F12 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "supplemented with 10% fetal calf serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "0.6% glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.37: Dissociated cells were then plated at a density of 106 cells in 35-mm dishes pre-coated with 10 g/ml polylysine (Sigma) and grown in a humidified atmosphere of 5% CO2, 95% air. 

Phrase: "Dissociated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "plated at a density of 106 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   757   C0162339:Cell Density [Quantitative Concept]
   757   C1166718:cells plate [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0178587:density [Quantitative Concept]
   748   C3282337:Cells [Cell]
   714   C0005971:Plate [Medical Device]
   714   C1139930:plate [Medical Device]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714   C3537155:Plate [Manufactured Object]

Phrase: "in 35-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "pre-coated with 10 g/ml polylysine"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C1300565:g/mL [Quantitative Concept]
   774 E C1637390:mL/g [Quantitative Concept]
   748   C0032518:Polylysine [Amino Acid, Peptide, or Protein]
   748   C0332152:Pre [Temporal Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C0740175:Pre [Qualitative Concept]
   748   C1522408:Coated [Qualitative Concept]
   748   C2257086:PRE [Genetic Function]
   714 E C0453946:Coat [Manufactured Object]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "grown in a humidified atmosphere of 5% CO2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0004178:Atmosphere [Natural Phenomenon or Process]
   744   C0678214:atmosphere [Quantitative Concept]
   744   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "95% air."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0001861:Air [Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.38: Transfection of 3F4-PrPc in primary cultured neurons was performed with Superfect (Qiagen). 

Phrase: "Transfection of 3F4-PrPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "in primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "was"

Phrase: "performed with Superfect"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Qiagen"

Phrase: ")."
Processing 00000000.tx.39: 3F4-HEK293 cells have been described previously (13). 

Phrase: "3F4-HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.40: Mouse embryonic fibroblasts devoid of p53 were obtained as described (17) from p53-/- mice established previously (18). 

Phrase: "Mouse embryonic fibroblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1516828:Mouse Embryonic Fibroblast [Tissue]
   896   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblasts [Cell]

Phrase: "devoid of p53"

Phrase: "were"

Phrase: "obtained as described"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(17"

Phrase: ")"

Phrase: "from p53-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "previously"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.41: Western Blot AnalysesCells were scraped and homogenized in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA containing 0.5% Triton X-100 and 0.5% sodium deoxycholate). 

Phrase: "Western Blot AnalysesCells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   734   C0949466:Western Blot [Laboratory Procedure]

Phrase: "were"

Phrase: "scraped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0184933:scraped [Therapeutic or Preventive Procedure]
  1000   C0444082:scraped [Body Substance]

Phrase: "and"

Phrase: "homogenized in lysis buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]

Phrase: "(50 mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "5 mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "0.5% sodium deoxycholate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.42: Equal amounts of protein (50 g) determined by the Bradford method (19) were separated on 12% SDS-PAGE and analyzed for their p53, active caspase-3, Mdm2, phospho-P38, and PrPc immunoreactivities by Western blot and hybridization with anti-p53 (mouse monoclonal Pab24, Santa Cruz Biotechnologies), anti-active caspase-3 (rabbit polyclonal, R&D Systems), mouse monoclonal anti-Mdm2 (20), anti-phospho-P38 (Promega), and anti-PrPc (SAF32 (21)), respectively. 

Phrase: "Equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(50 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "determined by the Bradford method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "(19"

Phrase: ")"

Phrase: "were"

Phrase: "separated on 12% SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "analyzed for their p53,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079419:P53 [Gene or Genome]
   770   C0936012:Analyzed [Research Activity]
   770   C1705526:p53 [Gene or Genome]

Phrase: "active caspase-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Mdm2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812222:MDM2 [Gene or Genome]
  1000   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "phospho-P38,"

Phrase: "and"

Phrase: "PrPc immunoreactivities by Western blot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "hybridization with anti-p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020202:Hybridisation [Genetic Function]
   770   C1300517:Hybridization [Laboratory Procedure]

Phrase: "(mouse monoclonal Pab24,"

Phrase: "Santa Cruz Biotechnologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnologies [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "anti-active caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(rabbit polyclonal, R&D Systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0205090:R- [Spatial Concept]
   804   C0684010:R. [Professional or Occupational Group]
   804   C2603358:R' [Clinical Attribute]
   771   C0449913:System [Functional Concept]
   771   C1553451:System [Manufactured Object]
   771   C1704459:System [Medical Device]
   721 E C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "mouse monoclonal anti-Mdm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0812222:MDM2 [Gene or Genome]
   812   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "anti-phospho-P38"

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti-PrPc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(SAF32"

Phrase: "(21"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.43: Flow Cytometry and TUNEL AnalysisCells were grown in 6-well plates and incubated for 15 h at 37 C in the presence or absence of staurosporine (0.5 M, Sigma) and then rinsed with PBS and suspended with 750 l of buffer (Tris 20 mM, tri-natrium citrate 0.1%, Triton X-100 0.05%) containing 50 g/ml propidium iodide. 

Phrase: "Flow Cytometry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "and"

Phrase: "TUNEL AnalysisCells"

Phrase: "were"

Phrase: "grown in 6-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "incubated for 15 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C in"

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of staurosporine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(0.5 M,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed with PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "suspended with 750 l of buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1553389:suspended [Idea or Concept]
   753   C1553403:suspended [Idea or Concept]
   753   C1705537:Suspended [Functional Concept]

Phrase: "(Tris 20 mM,"

Phrase: "tri-natrium citrate 0.1%,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0008857:Citrate [Organic Chemical]
   804   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   804   C0814229:TRI [Intellectual Product]

Phrase: "Triton X-100 0.05%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 g/ml propidium iodide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0021966:Iodide [Inorganic Chemical]
   804   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.44: Cells were left overnight at 4 C, and then the propidium iodide fluorescence of individual nuclei was measured as described previously (14). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "overnight at 4 C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the propidium iodide fluorescence of individual nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.45: For DNA nick-end labeling, cells were fixed for 20 min in 1% paraformaldehyde in phosphate-buffered saline, rinsed in phosphate-buffered saline, left overnight in 70% ethanol, and then processed for the dUTP nick-end labeling TUNEL technique according to manufacturer's recommendations (kit from Roche Applied Science). 

Phrase: "For DNA nick-end labeling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1167624:Labeling [Mental Process]
   812   C1947902:Labeling [Manufactured Object]
   812   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed for 20 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in 1% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "in phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "rinsed in phosphate-buffered saline,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726   C1701810:Rinse [Functional Concept]
   726   C1882955:Rinse [Activity]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "overnight in 70% ethanol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1381542:70% Ethanol [Clinical Drug]
   770   C0001962:Ethanol [Organic Chemical]
   770   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "processed for the dUTP nick-end labeling TUNEL technique"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   742   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0444930:End [Spatial Concept]
   742   C0449851:Technique [Functional Concept]
   742   C0600528:TUNEL [Molecular Biology Research Technique]
   742   C1167624:Labeling [Mental Process]
   742   C1522240:Processed [Phenomenon or Process]
   742   C1947902:Labeling [Manufactured Object]
   742   C2746065:End [Temporal Concept]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   708 E C0181496:Label [Manufactured Object]
   708 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "according to manufacturer's recommendations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034866:recommendations [Idea or Concept]

Phrase: "(kit from Roche Applied Science"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0812225:KIT [Medical Device]
   760   C1150635:KIT [Molecular Function]
   760   C1705212:Kit [Medical Device]
   760   C1705213:KIT [Medical Device]
   760   C3273202:Kit [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.46: Staining was assessed with a peroxidase-conjugated antibody and revealed with a diaminobenzidine substrate. 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "assessed with a peroxidase-conjugated antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0522529:Conjugated [Spatial Concept]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   753   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "revealed with a diaminobenzidine substrate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0443289:Revealed [Qualitative Concept]
   760   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.47: Caspase-3-like Activity AssayCells were cultured in 6-well plates for 15 h at 37 C in the absence or presence of staurosporine (0.5 M) (in some cases, cells were preincubated for 24 h with Ac-DEVD-al (100 M)). 

Phrase: "Caspase-3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like Activity AssayCells"

Phrase: "were"

Phrase: "cultured in 6-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "plates for 15 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0005971:Plate [Medical Device]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1139930:plate [Medical Device]
   770   C3537155:Plate [Manufactured Object]

Phrase: "at 37 C in"

Phrase: "the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of staurosporine"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "(0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "M) (in some cases,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with Ac-DEVD-al (100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1412573:AC [Gene or Genome]
   812   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   812   C3539770:AC [Gene or Genome]

Phrase: "M)"

Phrase: ")."
Processing 00000000.tx.48: Cells were then rinsed, gently scraped, pelleted by centrifugation, resuspended in 40 l of lysis buffer, and analyzed as detailed previously (22). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: ","

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "scraped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0184933:scraped [Therapeutic or Preventive Procedure]
  1000   C0444082:scraped [Body Substance]

Phrase: ","

Phrase: "pelleted by centrifugation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0441436:Pellet [Manufactured Object]
   756   C0993610:Pellet [Biomedical or Dental Material]
   756   C1998480:Pellet [Quantitative Concept]

Phrase: "resuspended in 40 l of lysis buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
   748   C0439509:/40 [Temporal Concept]
   748   C1536403:lysis [Cell Function]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "previously"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.49: p53 Transcriptional Activity and Its Promoter TransactivationOne g of PG13-luciferase, a p53 gene reporter construct described previously (23), was co-transfected with 1 g of a -galactosidase coding vector (to normalize transfections efficiencies) in 3F4-PrPc HEK293 cells, PrP+/+, or PrP-/- primary cultured neurons. 

Phrase: "p53 Transcriptional Activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Its Promoter TransactivationOne g of PG13-luciferase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]

Phrase: "a p53 gene reporter construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2827421:Construct [Classification]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "co-transfected with 1 g of a -galactosidase coding vector"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   757   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   739   C0009219:Coding [Occupational Activity]
   739   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0439267:g% [Quantitative Concept]
   739   C0442335:Vector [Spatial Concept]
   739   C1705099:Vector [Idea or Concept]
   706 E C0805701:Code [Intellectual Product]

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "transfections efficiencies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:efficiencies [Quantitative Concept]
   777 E C0442799:Efficient [Qualitative Concept]

Phrase: ")"

Phrase: "in 3F4-PrPc HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C2936239:HEK293 Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "PrP+/+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032027:PRP [Disease or Syndrome]

Phrase: "or"

Phrase: "PrP-/- primary cultured neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.50: Forty-eight hours after transfection, luciferase and -galactosidase activities were measured according to previously described procedures (23). 

Phrase: "Forty-eight hours after transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and -"

Phrase: "galactosidase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1150051:galactosidase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured according to previously described procedures"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   783   C0449768:Measured to [Quantitative Concept]
   753   C0025664:procedures [Intellectual Product]
   753   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C0444706:Measured [Qualitative Concept]
   753   C0680240:according [Social Behavior]
   753   C1552738:described [Idea or Concept]
   753   C2700391:procedures [Activity]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   719 E C3274430:PROCEDURE [Health Care Activity]
   719 E C3538935:Procedure [Idea or Concept]
   719 E C3539779:Procedure [Intellectual Product]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.51: Mouse p53 promoter was cloned as described (24) except that the same p53 promoter region was cloned upstream of luciferase instead of chloramphenicol acetyltransferase. 

Phrase: "Mouse p53 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "cloned as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009013:cloned [Cell]
   790   C1552738:described [Idea or Concept]
   756 E C1522642:Clone [Tissue]

Phrase: "(24"

Phrase: ")"

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that"

Phrase: "the same p53 promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017446:Region [Geographic Area]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "cloned upstream of luciferase"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0009013:cloned [Cell]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0522505:Upstream [Spatial Concept]
   737 E C1522642:Clone [Tissue]

Phrase: "instead of chloramphenicol acetyltransferase."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0008169:Chloramphenicol Acetyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0008168:Chloramphenicol [Antibiotic,Organic Chemical]
   805 E C0591251:Chloromycetin [Organic Chemical,Pharmacologic Substance]
   805 E C0699303:Ophthochlor [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.52: The same construct lacking the p53 sequence was used as control. 

Phrase: "The same construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the p53 sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "used as control."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1273517:used [Finding]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.53: Statistical AnalysisStatistical analysis was performed with Prism software (Graphpad Software, San Diego, CA) using the Newman-Keuls multiple comparison test for one-way analysis of variance and the unpaired Student's t test for pairwise comparisons.  

Phrase: "Statistical AnalysisStatistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed with Prism software"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0037585:Software [Intellectual Product,Manufactured Object]
   770   C0814195:PRISM [Intellectual Product]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
   715 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(Graphpad Software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Newman-Keuls multiple comparison test for one-way analysis of variance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0022885:Test [Laboratory Procedure]
   736   C0039593:Test [Functional Concept]
   736   C0392366:test [Intellectual Product]

Phrase: "and"

Phrase: "the unpaired Student's t test for pairwise comparisons."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C1710574:Unpaired t-Test [Intellectual Product]
   744   C0022885:Test [Laboratory Procedure]
   744   C0038492:student [Professional or Occupational Group]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C1551041:student [Idea or Concept]
   744   C1552573:student [Intellectual Product]
Processing 00000000.tx.54: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  PrPc-induced Apoptotic Phenotype Is Fully Dependent on p53 in Human Cells and FibroblastsWe have established previously that PrPc drastically potentiates staurosporine-induced caspase activation in neuronal TSM1 cells (14). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "PrPc-induced Apoptotic Phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031437:Phenotype [Organism Attribute]
   804   C1285572:Phenotype [Laboratory Procedure]

Phrase: "Is"

Phrase: "Fully Dependent on p53"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "in Human Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "FibroblastsWe"

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "previously"

Phrase: "that PrPc drastically"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "potentiates"

Phrase: "staurosporine-induced caspase activation in neuronal TSM1 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1159825:Caspase Activation [Molecular Function]
   767   C1326120:activation cells [Cell Function]
   744   C1879547:Activation [Activity]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.55: This phenotype is antagonized by the depletion of endogenous p53 by using an antisense approach (14). 

Phrase: "This phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "antagonized by the depletion of endogenous p53"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0079419:P53 [Gene or Genome]
   748   C0205227:Endogenous [Functional Concept]
   748   C0333668:Depletion [Functional Concept]
   748   C1705526:p53 [Gene or Genome]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antisense approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.56: Using a pharmacological approach, we have established here that a very potent and selective p53 inhibitor, pifithrin-, completely abolishes p53 transcriptional activity in human HEK293 cells (Fig. 1B). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a pharmacological approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "here"

Phrase: "that"

Phrase: "a very potent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "selective p53 inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "pifithrin-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0909264:pifithrin [Organic Chemical,Pharmacologic Substance]

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolishes"

Phrase: "p53 transcriptional activity in human HEK293 cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0020115:Human Activity [Activity]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.57: Furthermore, pifithrin- but not its inactive analog (Fig. 1A) fully inhibits the PrPc-dependent increase of staurosporine-induced caspase activation. 

Phrase: "Furthermore,"

Phrase: "pifithrin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0909264:pifithrin [Organic Chemical,Pharmacologic Substance]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "its inactive analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "fully"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the PrPc-dependent increase of staurosporine-induced caspase activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]
Processing 00000000.tx.58: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.59: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.60: Effect of pifithrin- on staurosporine-induced caspase-3 activity in mock-transfected and 3F4-PrPc-expressing HEK293 cells. 

Phrase: "Effect of pifithrin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on staurosporine-induced caspase-3 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C1150132:caspase-3 activity [Molecular Function]
   853   C1150130:caspase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "in mock-transfected"

Phrase: "and"

Phrase: "3F4-PrPc-expressing HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2936239:HEK293 Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.61: A, mock- and 3F4-PrPc-transfected HEK293 cells were treated for 16 h with 2 M staurosporine in the absence (CT, control) or presence of 1 M pifithrin- (PFT) or its inactive precursor analog (PC), and then caspase-3 activity was measured as described under "Materials and Methods." 

Phrase: "A,"

Phrase: "mock-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: "and"

Phrase: "3F4-PrPc-transfected HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2936239:HEK293 Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for 16 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with 2 M staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "presence of 1 M pifithrin- (PFT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "its inactive precursor analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:Analog [Chemical Viewed Structurally]
   727 E C0679213:analogies [Idea or Concept]

Phrase: "(PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540812:PC [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then caspase-3 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1150132:caspase-3 activity [Molecular Function]
   875   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.62: Bars are the means  S.E. of three independent determinations. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "are"

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of three independent determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.63: **, p < 0.01; 

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.64: ns, nonsignificant. 

Phrase: "ns,"

Phrase: "nonsignificant."
Processing 00000000.tx.65: B, under identical treatment conditions, pifithrin- fully abolishes p53 transcriptional activity measured as described under "Materials and Methods."  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "under identical treatment conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "pifithrin- fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0909264:pifithrin [Organic Chemical,Pharmacologic Substance]

Phrase: "abolishes"

Phrase: "p53 transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.66: We previously documented the fact that PrPc increases p38-like immunoreactivity and controls Mdm2-dependent p53 metabolic stability in TSM1 cells (14). 

Phrase: "We previously"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "the fact"

Phrase: "that PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "p38-"

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Mdm2-dependent p53 metabolic stability in TSM1 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205360:Stability [Qualitative Concept]
   744   C2347098:Stability [Qualitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.67: Here we show that besides this post-transcriptional effect, PrPc also exerts transcriptional control of p53. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that besides this post-transcriptional effect,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0040649:Transcriptional [Genetic Function]
   753   C0687676:Post [Temporal Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C1704687:Post [Manufactured Object]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "PrPc also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "transcriptional control of p53."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1158770:Transcriptional Control [Genetic Function]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.68: Thus, 3F4-HEK293 cells display a significantly higher p53 promoter transactivation than mock-transfected cells as indicated by the luciferase reporter activity (Fig. 2). 

Phrase: "Thus,"

Phrase: "3F4-HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a significantly higher p53 promoter transactivation than mock-transfected cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0040624:Transactivation [Genetic Function]

Phrase: "as"

Phrase: "indicated by the luciferase reporter activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C1151115:luciferase activity [Molecular Function]
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0205177:Activity [Functional Concept]
   753   C0335038:Reporter [Professional or Occupational Group]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1444656:Indicated [Finding]
   753   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   753   C1561536:*Activity [Idea or Concept]
   753   C1705915:Reporter [Conceptual Entity]
   753   C1709908:Reporter [Group]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.69: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.70: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.71: PrPc expression increases p53 promoter transactivation. 

Phrase: "PrPc expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
   734   C1418941:PRION PROTEIN [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "p53 promoter transactivation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040624:Transactivation [Genetic Function]
Processing 00000000.tx.72: Transactivation of the p53 promoter was measured as described under "Materials and Methods" in mock-transfected or 3F4-PrPc-expressing HEK293 cells. 

Phrase: "Transactivation of the p53 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040624:Transactivation [Genetic Function]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "in mock-transfected"

Phrase: "or"

Phrase: "3F4-PrPc-expressing HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2936239:HEK293 Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.73: Bars are the means  S.E. of luciferase activities (to which control luciferase activity was subtracted) measured in 12 independent determinations. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "are"

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of luciferase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1151115:luciferase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "to which"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "subtracted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1719767:Subtract [Intellectual Product]
   966   C2348589:Subtract [Phenomenon or Process]

Phrase: ")"

Phrase: "measured in 12 independent determinations."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0085862:Independent [Idea or Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C0680730:determinations [Governmental or Regulatory Activity]
   760   C1299583:Independent [Finding]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.74: ***, p < 0.001.  

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.75: We have previously established a link between p53 and the PrPc-induced phenotype using fibroblasts in which the p53 gene harbors a loss-of-function mutation. 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "a link between p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "the PrPc-induced phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031437:Phenotype [Organism Attribute]
   812   C1285572:Phenotype [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fibroblasts in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0016030:Fibroblasts [Cell]

Phrase: "the p53 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079419:p53 gene [Gene or Genome]
  1000   C1705526:p53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "harbors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "a loss-of-function mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.76: To confirm this finding and preclude the possibility of a refolding/restoration of p53 activity after the chaperoning of mutated p53 (25), we have now switched to a fibroblastic cell line in which p53 has been invalidated and examined the phenotype triggered by overexpression of PrPc. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "and"

Phrase: "preclude"

Phrase: "the possibility of a refolding/restoration of p53 activity"

Phrase: "after the chaperoning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of mutated p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079419:P53 [Gene or Genome]
   861   C1705526:p53 [Gene or Genome]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "switched to a fibroblastic cell line"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0682524:fibroblast cell line [Cell]
   790   C0007600:Cell Line [Cell]
   754   C0016030:fibroblast cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:Line [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C1707719:Switch [Manufactured Object]

Phrase: "in which p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "invalidated"

Phrase: "and"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "triggered by overexpression of PrPc."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   790   C1418941:PRION PROTEIN [Gene or Genome]
   790   C1444748:Triggered by [Qualitative Concept]
           Trigger
   783   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719   C0032930:Trigger [Clinical Attribute]
Processing 00000000.tx.77: In the absence of p53, there is an important staurosporine-induced caspase-3 activation (Fig. 3B). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of p53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "there"

Phrase: "is"

Phrase: "an important staurosporine-induced caspase-3 activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C1159825:Caspase Activation [Molecular Function]
   799   C1879547:Activation [Activity]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.78: Interestingly, this p53-independent caspase activity was not enhanced by PrPc (Fig. 3B), whereas the combination of PrPc expression and p53 complementation led to an additional increase of caspase-3 activity (Fig. 3B). 

Phrase: "Interestingly,"

Phrase: "this p53-independent caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhanced by PrPc"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   833   C1418941:PRION PROTEIN [Gene or Genome]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2349975:Enhanced [Activity]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the combination of PrPc expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "p53 complementation"

Phrase: "led to an additional increase of caspase-3 activity"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   790   C1150132:caspase-3 activity [Molecular Function]
   764   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1150130:caspase activity [Molecular Function]
   742   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0442805:Increase [Functional Concept]
   742   C1524062:Additional [Functional Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1708698:LED [Manufactured Object]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.79: Finally, the co-transfection of PrPc with p53 cDNA drastically potentiated the p53 transcriptional activity exhibited by p53 cDNA transfection alone (Fig. 3A). 

Phrase: "Finally,"

Phrase: "the co-transfection of PrPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with p53 cDNA drastically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "potentiated"

Phrase: "the p53 transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "exhibited by p53 cDNA transfection"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   760   C0079419:P53 [Gene or Genome]
   760   C1705526:p53 [Gene or Genome]
   726   C0015272:Exhibit [Intellectual Product]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.80: Altogether, these data, combined with those observed after pifithrin- inhibition, clearly indicate that the PrPc proapoptotic phenotype is completely dependent on p53 and that the latter is controlled by PrPc at both the transcriptional (Fig. 2) and post-transcriptional (14) levels in human and neuronal cells. 

Phrase: "Altogether,"

Phrase: "these data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "combined with those observed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205195:Combined [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "after"

Phrase: "pifithrin- inhibition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "clearly"

Phrase: "indicate"

Phrase: "that"

Phrase: "the PrPc proapoptotic phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031437:Phenotype [Organism Attribute]
   812   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "completely dependent on p53"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the latter"

Phrase: "is"

Phrase: "controlled by PrPc"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   833   C0332298:Controlled by [Functional Concept]
   833   C1418941:PRION PROTEIN [Gene or Genome]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "at both"

Phrase: "the transcriptional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcriptional [Genetic Function]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "post-transcriptional"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0040649:Transcriptional [Genetic Function]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "levels in human"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.81: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.82: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.83: Effect of PrPc transfection on caspase-3 and p53 transcriptional activities in p53-deficient fibroblasts. 

Phrase: "Effect of PrPc transfection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p53 transcriptional activities in p53-deficient fibroblasts."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.84: A, p53 transcriptional activity was monitored as described under "Materials and Methods" after transient transfections of p53 knock-out fibroblasts with empty pcDNA3 vector, 3F4MoPrPc (PrPc), or p53 cDNA (p53) alone or in combination (PrPc/p53). 

Phrase: "A,"

Phrase: "p53 transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "after"

Phrase: "transient transfections of p53 knock-out fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "with empty pcDNA3 vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "3F4MoPrPc"

Phrase: "(PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "p53 cDNA (p53"

Phrase: ")"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "(PrPc/p53"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0080055:Protein p53 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079419:P53 [Gene or Genome]
   827   C1705526:p53 [Gene or Genome]
   734   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
   734   C1418941:PRION PROTEIN [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.85: In B, caspase-3 activity was measured after identical transient transfection of the indicated cDNA in p53-deficient fibroblasts treated (+) or not (-) with staurosporine. 

Phrase: "In B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "caspase-3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured after identical transient transfection of the indicated cDNA"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   742   C0040704:Transient [Population Group]
   742   C0205280:Identical [Qualitative Concept]
   742   C0205374:Transient [Temporal Concept]
   742   C0444706:Measured [Qualitative Concept]
   742   C1444656:Indicated [Finding]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]

Phrase: "in p53-deficient fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "or"

Phrase: "not (-) with staurosporine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.86: Bars represent the means of six determinations  S.E. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means of six determinations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.87: **, p < 0.05.  

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.88: PrP-/- Primary Cultured Neurons Display Lower Susceptibility to StaurosporineOur previous statements above were based on several cell lines overexpressing PrPc. 

Phrase: "PrP-/- Primary Cultured Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "Display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "Lower Susceptibility to StaurosporineOur previous statements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "above"

Phrase: "were"

Phrase: "based on several cell lines"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1527178:Based [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705938:Based [Idea or Concept]
   760   C1948049:Cell [Spatial Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PrPc."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.89: It was therefore important to assess the contribution of endogenous PrPc. 

Phrase: "It"

Phrase: "was"

Phrase: "therefore important to"

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the contribution of endogenous PrPc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]
Processing 00000000.tx.90: We thus measured the staurosporine susceptibility of primary cultured neurons from Zrch-1 mice embryos in which the Prnp gene had been disrupted (15). 

Phrase: "We thus"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the staurosporine susceptibility of primary cultured neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "from Zrch-1 mice embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013935:Embryos [Embryonic Structure]
   779 E C1305370:Embryo [Embryonic Structure]

Phrase: "in which"

Phrase: "the Prnp gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418941:PRNP gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "had"

Phrase: "been"

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.91: As expected, these neurons do not display any PrPc-like immunoreactivity (Fig. 4A). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "these neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "any PrPc-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.92: That PrP-/- neurons exhibit lower staurosporine-induced responses is evidenced by both TUNEL (Fig. 4, B and C) and DNA fragmentation (Table I) analyses. 

Phrase: "That PrP-/- neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "lower staurosporine-induced responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "evidenced by both TUNEL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600528:TUNEL [Molecular Biology Research Technique]
   737   C0332120:Evidence [Functional Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "DNA fragmentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "(Table I) analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
Processing 00000000.tx.93: Clearly, the staurosporine-induced increase in the number of apoptotic nuclei observed in PrP+/+ neurons is drastically lowered in neurons devoid of PrPc (Fig. 4, B and C). 

Phrase: "Clearly,"

Phrase: "the staurosporine-induced increase in the number of apoptotic nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "observed in PrP+/+ neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027882:Neurons [Cell]
   770   C0032027:PRP [Disease or Syndrome]
   770   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "drastically"

Phrase: "lowered in neurons"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0027882:Neurons [Cell]
   790   C0441994:lowered [Spatial Concept]
   790   C1272755:Lowered [Quantitative Concept]
   790   C2003888:Lowered [Activity]
   756 E C1548802:Lower [Body Location or Region]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "devoid of PrPc"

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.94: This lower staurosporine susceptibility exhibited by PrP-/- primary cultured neurons is accompanied by lowered caspase-3-like immunoreactivity (Fig. 5A) and activity (Fig. 5B). 

Phrase: "This lower staurosporine susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0012655:Susceptibility [Clinical Attribute]
   827   C0220898:Susceptibility [Organism Attribute]
   827   C1264642:Susceptibility [Functional Concept]
   827   C1547045:*Susceptibility [Quantitative Concept]
   755 E C0231204:Susceptible [Functional Concept]
   755 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "exhibited by PrP-/- primary cultured neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0027882:Neurons [Cell]
   753   C0032027:PRP [Disease or Syndrome]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   719   C0015272:Exhibit [Intellectual Product]

Phrase: "is"

Phrase: "accompanied by lowered caspase-3-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0441994:lowered [Spatial Concept]
   760   C1272755:Lowered [Quantitative Concept]
   760   C2003888:Lowered [Activity]
   726 E C1548802:Lower [Body Location or Region]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.95: It is noteworthy that the effect of staurosporine is dose-dependent in both PrP+/+ and PrP-/- cells, as was another apoptotic effector, ceramide C2 (Fig. 5, C and D). 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "the effect of staurosporine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "dose-dependent in both PrP+/+"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1512045:Dose-dependent [Quantitative Concept]
   760   C0178602:Dose [Quantitative Concept]
   760   C0851827:Dependent [Qualitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "PrP-/- cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "was"

Phrase: "another apoptotic effector,"

Phrase: "ceramide C2 (Fig. 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007745:Ceramide [Biologically Active Substance,Lipid]
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.96: However, the effect triggered by both pharmacological agents always remains lower in PrP-/- neurons than in PrP+/+ neurons. 

Phrase: "However,"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "triggered by both pharmacological agents always"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1444748:Triggered by [Qualitative Concept]
           Trigger
   753   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   753   C0205464:pharmacological [Functional Concept]
   753   C2003902:Always [Temporal Concept]
   723   C1254351:Pharmacologic Agent [Pharmacologic Substance]
           Agent
   719   C0032930:Trigger [Clinical Attribute]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1521826:Agent [Intellectual Product]

Phrase: "remains"

Phrase: "lower in PrP-/- neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in PrP+/+ neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.97: View larger version (62K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(62K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.98: 4. 

Phrase: "4."
Processing 00000000.tx.99: TUNEL-positive neurons are lower in PrP-/- than in wild-type primary cultured neurons. 

Phrase: "TUNEL-positive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "lower in PrP-/-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in wild-type primary cultured neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.100: A, endogenous PrPc-like immunoreactivity was visualized in PrP+/+ and PrP-/- neurons as described under "Materials and Methods." 

Phrase: "A,"

Phrase: "endogenous PrPc-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "visualized in PrP+/+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032027:PRP [Disease or Syndrome]
   790   C0234621:Visualized [Functional Concept]

Phrase: "and"

Phrase: "PrP-/- neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.101: In B, TUNEL labeling was measured in the absence (-) or presence (+) of staurosporine in the indicated neurons. 

Phrase: "In B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "TUNEL labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "measured in the absence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(-"

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "of staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "in the indicated neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.102: Cell death is visualized by black precipitates and quantified (C) as detailed under "Materials and Methods."  

Phrase: "Cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "visualized by black precipitates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0234621:Visualized [Functional Concept]
   770   C0439541:Black [Qualitative Concept]
   737   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "quantified"

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "as"

Phrase: "detailed under ""Materials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.103: View this table: [in this window] [in a new window]  TABLE I Basal and staurosporine-stimulated propidium iodide incorporation measured in the indicated cell lines by flow cytometry analysis Data are the means of three independent experiments.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "staurosporine-stimulated propidium iodide incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0243126:incorporation [Functional Concept]

Phrase: "measured in the indicated cell lines"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1444656:Indicated [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "by flow cytometry analysis Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "the means of three independent experiments."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C1704970:Means [Conceptual Entity]
   719 E C0444504:Mean [Quantitative Concept]
   719 E C2347634:Mean [Quantitative Concept]
   719 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.104: View larger version (25K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.105: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.106: Depletion of endogenous PrPc lowers the responsiveness of primary cultured neurons to staurosporine and ceramide C2. 

Phrase: "Depletion of endogenous PrPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333668:Depletion [Functional Concept]

Phrase: "lowers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the responsiveness of primary cultured neurons"

Phrase: "to staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ceramide C2."
Processing 00000000.tx.107: Primary cultured neurons were obtained from 14-day-old mouse embryos from wild-type mice (PrP+/+) or Zrch-1 mice in which the Prnp gene had been deleted (PrP-/-) and cultured as described under "Materials and Methods." 

Phrase: "Primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "obtained from 14-day-old mouse embryos"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   748   C0013935:Embryos [Embryonic Structure]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0332173:/day [Temporal Concept]
   748   C0439228:day [Temporal Concept]
   748   C0439505:/day [Temporal Concept]
   748   C0580836:Old [Temporal Concept]
   748   C1301820:Obtained [Functional Concept]
   714 E C1305370:Embryo [Embryonic Structure]
   714 E C1706701:Obtain [Activity]

Phrase: "from wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(PrP+/+)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032027:PRP [Disease or Syndrome]

Phrase: "or"

Phrase: "Zrch-1 mice in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "the Prnp gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418941:PRNP gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "had"

Phrase: "been"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "(PrP-/-)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032027:PRP [Disease or Syndrome]

Phrase: "and"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.108: Caspase-3-like immunoreactivity (A) and activity (B) were measured in the indicated cell lines in control (-) and staurosporine (Sts)-stimulated (+) conditions. 

Phrase: "Caspase-3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "(A)"

Phrase: "and"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "measured in the indicated cell lines"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1444656:Indicated [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(-"

Phrase: ")"

Phrase: "and"

Phrase: "staurosporine (Sts)-stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(+"

Phrase: ")"

Phrase: "conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.109: The bars in B correspond to the Ac-DEVD-al-sensitive Ac-DEVD-7AMC hydrolyzing activity and are the means  S.E. of four experiments (duplicate determinations). 

Phrase: "The bars in B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1707156:BARS [Gene or Genome]
   770   C3274014:BARS [Intellectual Product]
   770   C3541345:BARS [Intellectual Product]

Phrase: "correspond"

Phrase: "to the Ac-DEVD-al-sensitive Ac-DEVD-7AMC hydrolyzing activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0205177:Activity [Functional Concept]
   791   C0439167:% activity [Quantitative Concept]
   791   C0441655:Activity [Activity]
   791   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "are"

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of four experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "(duplicate determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.110: C and D, PrP+/+ and PrP-/- cultured neurons were incubated with increasing concentrations of staurosporine (C) or ceramide C2 (D), and then caspase-3 was measured as described. 

Phrase: "C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "PrP+/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032027:PRP [Disease or Syndrome]

Phrase: "and"

Phrase: "PrP-/- cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "incubated with increasing concentrations of staurosporine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0442808:Increasing [Functional Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "ceramide C2 ("

Phrase: "D)"

Phrase: ","

Phrase: "and"

Phrase: "then caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.111: The bars show the percent of control corresponding to caspase activity recovered in untreated PrP-/- neurons and represent the means  S.E. of three independent experiments.  

Phrase: "The bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the percent of control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439165:Percent [Quantitative Concept]

Phrase: "corresponding to caspase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1150130:caspase activity [Molecular Function]
   770   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "recovered in untreated PrP-/- neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0027882:Neurons [Cell]
   760   C0032027:PRP [Disease or Syndrome]
   760   C0332155:untreated [Finding]
   760   C0521108:recovered [Qualitative Concept]
   726 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.112: PrPc Complementation Partially Restores Staurosporine-induced Caspase-3 Activation in PrP-/- Primary Cultured NeuronsTransient transfection of PrP+/+ neurons with 3F4MoPrPc cDNA led to enhanced PrPc-like immunoreactivity (Fig. 6A, upper panel). 

Phrase: "PrPc Complementation Partially"

Phrase: "Restores"

Phrase: "Staurosporine-induced Caspase-3 Activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C1159825:Caspase Activation [Molecular Function]
   804   C1879547:Activation [Activity]

Phrase: "in PrP-/- Primary Cultured NeuronsTransient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of PrP+/+ neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "with 3F4MoPrPc cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "led to enhanced PrPc-"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   806   C1418941:PRION PROTEIN [Gene or Genome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1708698:LED [Manufactured Object]
   760   C2349975:Enhanced [Activity]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.113: The treatment of mock-transfected PrP+/+ neurons with staurosporine increases caspase-3-like immunoreactivity, a phenotype that was drastically enhanced in 3F4MoPrPc-transfected primary cultured neurons (Fig. 6A, lower panel). 

Phrase: "The treatment of mock-transfected PrP+/+ neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "with staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "caspase-3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like immunoreactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "a phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "that"

Phrase: "was"

Phrase: "drastically"

Phrase: "enhanced in 3F4MoPrPc-transfected primary cultured neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0027882:Neurons [Cell]
   748   C0205225:Primary [Qualitative Concept]
   748   C0439631:Primary [Therapeutic or Preventive Procedure]
   748   C2349975:Enhanced [Activity]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.114: Accordingly, this was accompanied by a consistent elevation of staurosporine-induced caspase activation upon 3F4MoPrP transfection of PrP+/+ neurons (Fig. 6B). 

Phrase: "Accordingly,"

Phrase: "this"

Phrase: "was"

Phrase: "accompanied by a consistent elevation of staurosporine-induced caspase activation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C1159825:Caspase Activation [Molecular Function]
   739   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   739   C0205263:Induced [Functional Concept]
   739   C0332290:Consistent [Idea or Concept]
   739   C0439775:Elevation [Therapeutic or Preventive Procedure]
   739   C0702240:Elevation [Spatial Concept]
   739   C1879547:Activation [Activity]

Phrase: "upon 3F4MoPrP transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of PrP+/+ neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.115: These data indicate that primary cultured neurons were transfectable and that 3F4MoPrPc overexpression in these cells mimics and potentiates the staurosporine-stimulated caspase activation phenotype observed in untransfected primary cultured neurons (see Fig. 5). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "transfectable"

Phrase: "and"

Phrase: "that 3F4MoPrPc overexpression in these cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "potentiates"

Phrase: "the staurosporine-stimulated caspase activation phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031437:Phenotype [Organism Attribute]
   804   C1285572:Phenotype [Laboratory Procedure]

Phrase: "observed in untransfected primary cultured neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0027882:Neurons [Cell]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.116: View larger version (34K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.117: 6. 

Phrase: "6."
Processing 00000000.tx.118: PrPc cDNA transfection increases staurosporine-induced caspase activity and immunoreactivity in PrP+/+ neurons. 

Phrase: "PrPc cDNA transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "staurosporine-induced caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "immunoreactivity in PrP+/+ neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.119: After transient transfection of wild-type primary cultured neurons (PrP+/+) with 3F4MoPrPc cDNA or empty vector (pcDNA3), PrPc- and caspase-3-like (casp.3) immunoreactivities (A) and caspase activity (B) were measured under control (-) and staurosporine-stimulated (+) conditions (see "Materials and Methods" for details). 

Phrase: "After transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of wild-type primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(PrP+/+) with 3F4MoPrPc cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032027:PRP [Disease or Syndrome]

Phrase: "or"

Phrase: "empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "(pcDNA3"

Phrase: ")"

Phrase: ","

Phrase: "PrPc-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "caspase-3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like"

Phrase: "(casp.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0291573:CASP-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "immunoreactivities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0597879:immunoreactivity [Molecular Function]

Phrase: "(A)"

Phrase: "and"

Phrase: "caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "measured under control"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0243148:control [Qualitative Concept]
   790   C0444706:Measured [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(-"

Phrase: ")"

Phrase: "and"

Phrase: "staurosporine-stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(+"

Phrase: ")"

Phrase: "conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(see ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "for details"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: ")."
Processing 00000000.tx.120: Experiments in B correspond to three independent transfections with 3F4MoPrPc cDNA.  

Phrase: "Experiments in B"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0681814:Experiments [Research Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "correspond"

Phrase: "to three independent transfections with 3F4MoPrPc cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.121: We took advantage of this feature to examine whether the lowering of caspase activation observed in PrP-/- primary cultured neurons could be rescued even partially by 3F4MoPrPc overexpression. 

Phrase: "We"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "advantage of this feature to"

Phrase: "examine"

Phrase: "whether"

Phrase: "the lowering of caspase activation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0441994:lowering [Spatial Concept]
   760   C2003888:Lowering [Activity]
   726 E C1548802:Lower [Body Location or Region]

Phrase: "observed in PrP-/- primary cultured neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0027882:Neurons [Cell]
   753   C0032027:PRP [Disease or Syndrome]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "rescued"

Phrase: "even partially by 3F4MoPrPc overexpression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]
Processing 00000000.tx.122: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.123: 7A shows that a PrPc-like immunoreactivity was detectable in 3F4MoPrPc-transfected PrP-/- neurons. 

Phrase: "7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a PrPc-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detectable in 3F4MoPrPc-transfected PrP-/- neurons."
Processing 00000000.tx.124: This was accompanied by a partial but reproducible recovery of the staurosporine-induced caspase activation responsiveness displayed by PrP+/+ neurons (Fig. 7B). 

Phrase: "This"

Phrase: "was"

Phrase: "accompanied by a partial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0728938:Partial [Quantitative Concept]
   770   C1550516:partial [Idea or Concept]

Phrase: "but"

Phrase: "reproducible recovery of the staurosporine-induced caspase activation responsiveness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0237820:Recovery [Activity]
   742   C1555688:recovery [Idea or Concept]
   742   C2004454:Recovery [Organism Function]

Phrase: "displayed by PrP+/+ neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0027882:Neurons [Cell]
   770   C0032027:PRP [Disease or Syndrome]
   770   C0870432:displayed [Functional Concept]
   737 E C1705417:Display [Manufactured Object]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.125: Thus, although mock-transfected PrP-/- display only 54% of the responsiveness of PrP+/+ neurons to staurosporine, three distinct 3F4MoPrP transfections of PrP-/- neurons consistently restored the staurosporine-induced caspase-3 activation to about 81% of the control. 

Phrase: "Thus,"

Phrase: "although"

Phrase: "mock-transfected PrP-/- display only 54% of the responsiveness"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0032027:PRP [Disease or Syndrome]
   742   C0205171:Only [Quantitative Concept]
   742   C0562577:mock [Finding]
   742   C1705417:Display [Manufactured Object]
   742   C1720467:Only [Intellectual Product]

Phrase: "of PrP+/+ neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "to staurosporine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "three distinct 3F4MoPrP transfections of PrP-/- neurons consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "restored"

Phrase: "the staurosporine-induced caspase-3 activation to about 81%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1159825:Caspase Activation [Molecular Function]
   742   C1879547:Activation [Activity]

Phrase: "of the control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.126: (Fig. 7B). 

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.127: This incomplete rescue is in apparent agreement with the relatively low efficiency of 3F4MoPrP cDNA transfection illustrated by the expression of exogenous PrPc in PrP-/- primary cultured neurons and agrees well with all of the data described above. 

Phrase: "This incomplete rescue"

Phrase: "is in apparent agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0680240:Agreement [Social Behavior]
   770   C0750489:apparent [Idea or Concept]

Phrase: "with the relatively low efficiency"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0013682:Efficiency [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "of 3F4MoPrP cDNA transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "illustrated by the expression of exogenous PrPc"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   770   C1418941:PRION PROTEIN [Gene or Genome]
   767   C1171362:expression protein [Genetic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205101:Exogenous [Spatial Concept]
   744   C0205228:Exogenous [Functional Concept]

Phrase: "in PrP-/- primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "agrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3641827:Agree [Intellectual Product]

Phrase: "well with all of the data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205170:Well [Qualitative Concept]
   753   C1511726:Data [Idea or Concept]
   753   C3146287:Well [Manufactured Object]
   753   C3245479:data [Medical Device]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.128: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 7. 

Phrase: "7."
Processing 00000000.tx.130: PrPc cDNA transfection partially restores staurosporine-induced caspase activation in PrP-/- neurons. 

Phrase: "PrPc cDNA transfection partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "restores"

Phrase: "staurosporine-induced caspase activation in PrP-/- neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1159825:Caspase Activation [Molecular Function]
   748   C1879547:Activation [Activity]
Processing 00000000.tx.131: Transient transfection of PrPc cDNA in PrP-/- neurons increases PrPc immunoreactivity (A) and partially restores staurosporine-induced caspase activation (B). 

Phrase: "Transient transfection of PrPc cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "in PrP-/- neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "PrPc immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0597879:immunoreactivity [Molecular Function]
   734   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
   734   C1418941:PRION PROTEIN [Gene or Genome]

Phrase: "(A)"

Phrase: "and"

Phrase: "partially"

Phrase: "restores"

Phrase: "staurosporine-induced caspase activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1159825:Caspase Activation [Molecular Function]
   812   C1879547:Activation [Activity]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.132: Bars correspond to the staurosporine-induced increase of caspase-3 activity expressed as the percent of control corresponding to staurosporine stimulation of wild type PrP+/+ neurons transiently transfected with empty pcDNA3 vector (means of three independent transfections with 3F4MoPrPc cDNA).  

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "correspond to the staurosporine-induced increase of caspase-3 activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C1150132:caspase-3 activity [Molecular Function]
   760   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1150130:caspase activity [Molecular Function]
   739   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0205263:Induced [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C0442805:Increase [Functional Concept]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "expressed as the percent of control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0243148:control [Qualitative Concept]
   753   C0439165:Percent [Quantitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "corresponding to staurosporine stimulation of wild type PrP+/+ neurons transiently"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C1883559:Wild Type [Organism Attribute]
   741   C0682689:neuron type [Cell]
   739   C0027882:Neurons [Cell]
   739   C0032027:PRP [Disease or Syndrome]
   739   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]
   739   C0332307:Type [Qualitative Concept]
   739   C0445392:Wild [Intellectual Product]
   739   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   739   C1547052:*Type [Quantitative Concept]
   739   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "transfected with empty pcDNA3 vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]

Phrase: "(means of three independent transfections"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "with 3F4MoPrPc cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.133: PrP-/- Neurons Display Lower p53 Expression and ActivityWe examined the putative modulation of the tumor suppressor oncogene p53 by endogenous PrPc. 

Phrase: "PrP-/- Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "Display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "Lower p53 Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "ActivityWe"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the putative modulation of the tumor suppressor oncogene p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0443264:Modulation [Spatial Concept]

Phrase: "by endogenous PrPc."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.134: Primary cultured neurons devoid of their endogenous PrPc content display decreased p53 immunoreactivity (Fig. 8A) and transcriptional activity (Fig. 8B), thereby demonstrating that endogenous PrPc controls p53 expression and activity. 

Phrase: "Primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "devoid of their endogenous PrPc content display decreased p53 immunoreactivity"

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "demonstrating"

Phrase: "that endogenous PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "p53 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.135: Of greatest interest was the observation that p53 expression in the 1-month-old mouse brain was drastically lower in PrP-/- than in wild-type mice (Fig. 8C), indicating that PrPc also controls p53 expression in vivo. 

Phrase: "Of greatest interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0543488:Interest [Mental Process]

Phrase: "was"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that p53 expression in the 1-month-old mouse brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "drastically lower in PrP-/-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(Fig. 8C"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that PrPc also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "p53 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.136: View larger version (28K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.137: 8. 

Phrase: "8."
Processing 00000000.tx.138: Endogenous PrPc modulates p53-like immunoreactivity and transcriptional activity. 

Phrase: "Endogenous PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "p53-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "transcriptional activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.139: p53-like immunoreactivity (A and C) and transcriptional activity (B) were monitored as described under "Materials and Methods" in PrP+/+ and PrP-/- primary cultured neurons (A and B) and in adult mouse brain homogenate (C). 

Phrase: "p53-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "(A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "in PrP+/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032027:PRP [Disease or Syndrome]

Phrase: "and"

Phrase: "PrP-/- primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and in adult mouse brain homogenate"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1521713:Mouse Brain [Tissue]
   753   C0001675:Adult [Age Group]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1515981:And [Idea or Concept]
   753   C1706450:Adult [Human]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.140: Bars represent the means  S.E. of 4-6 independent experiments (triplicate determinations). 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of 4-6 independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "(triplicate determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.141: Mdm2-like immunoreactivity (D) and phosphorylated p38 MAPK (E) were measured in PrP-/- and PrP+/+ primary cultured neurons as detailed under "Materials and Methods."  

Phrase: "Mdm2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812222:MDM2 [Gene or Genome]
  1000   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "("

Phrase: "D)"

Phrase: "and"

Phrase: "phosphorylated p38 MAPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(E)"

Phrase: "were"

Phrase: "measured in PrP-/-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032027:PRP [Disease or Syndrome]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "PrP+/+ primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as"

Phrase: "detailed under ""Materials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.142: PrPc Controls Post-transcriptional Modulators of p53 ActivityWe searched for post-transcriptional modulators of p53 activity that would be under the control of endogenous PrP in primary cultured neurons. 

Phrase: "PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Post-transcriptional Modulators of p53 ActivityWe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1709060:Modulator [Manufactured Object]

Phrase: "searched for post-transcriptional modulators of p53 activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   744   C0040649:Transcriptional [Genetic Function]
   744   C0079419:P53 [Gene or Genome]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0687676:Post [Temporal Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C1704687:Post [Manufactured Object]
   744   C1705526:p53 [Gene or Genome]
   744   C1706202:Searched [Activity]
   711 E C1552603:search [Intellectual Product]
   711   C1709060:Modulator [Manufactured Object]

Phrase: "that"

Phrase: "would"

Phrase: "be under the control of endogenous PrP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0032027:PRP [Disease or Syndrome]
   748   C0205227:Endogenous [Functional Concept]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2987476:Be [Conceptual Entity]
   748   C3274648:Control [Qualitative Concept]

Phrase: "in primary cultured neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.143: Mdm2 was recently shown to decrease p53 metabolic stability thereby lowering its activity (20). 

Phrase: "Mdm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812222:MDM2 [Gene or Genome]
  1000   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "p53 metabolic stability thereby"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0205360:Stability [Qualitative Concept]
   812   C2347098:Stability [Qualitative Concept]
   741 E C1547311:Stable [Intellectual Product]

Phrase: "lowering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441994:lowering [Spatial Concept]
  1000   C2003888:Lowering [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.144: We demonstrate here that Mdm2 immunoreactivity is higher in PrP-/- than in wild-type neurons (Fig. 8D), a phenotype completely opposite from that observed for p53 immunoreactivity (see Fig. 5A). 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "here"

Phrase: "that Mdm2 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "is"

Phrase: "higher in PrP-/-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "than"

Phrase: "in wild-type neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 8D"

Phrase: ")"

Phrase: ","

Phrase: "a phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "completely opposite from that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521805:Opposite [Spatial Concept]

Phrase: "observed for p53 immunoreactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0079419:P53 [Gene or Genome]
   770   C0597879:immunoreactivity [Molecular Function]
   770   C1441672:Observed [Functional Concept]
   770   C1705526:p53 [Gene or Genome]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.145: As p38 mitogen-activated protein kinase (p38 MAPK) was reported to up-regulate p53 activity via upstream of Mdm2 expression (26), we also examined the endogenous levels of the active, phosphorylated counterpart of p38 MAPK. 

Phrase: "As p38 mitogen-activated protein kinase"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "(p38 MAPK)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "up-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "p53 activity via"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "upstream of Mdm2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "we also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the endogenous levels of the active, phosphorylated counterpart of p38 MAPK."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   738   C0441889:Levels [Qualitative Concept]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.146: Active p38 immunoreactivity was higher in wild-type than in PrP-/- neurons (Fig. 8E), suggesting that PrPc also controls p38 phosphorylation at endogenous levels.  

Phrase: "Active p38 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "higher in wild-type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in PrP-/- neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig. 8E"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that PrPc also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "p38 phosphorylation at endogenous levels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.147: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Spongiform encephalopathies comprise a group of several transmissible diseases known for a long time to affect animals and are always characterized at their late stages by neurodegenerescence and ultimately death (1, 27-30). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Spongiform encephalopathies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0162534:Spongiform encephalopathy [Disease or Syndrome]
   861   C0085584:Encephalopathies [Disease or Syndrome]
   827 E C1963101:Encephalopathy [Finding]

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "a group of several transmissible diseases"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0441835:a group [Classification]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "known for a long time to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0040223:Time [Temporal Concept]
   753   C0205166:Long [Qualitative Concept]
   753   C0205309:Known [Qualitative Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "are"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "characterized at their late stages"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C1279941:late stages [Temporal Concept]
   760   C0205087:Late [Temporal Concept]
   760   C1306673:Stages [Qualitative Concept]
   760   C1880022:Characterized [Activity]
   726 E C0205390:Stage [Temporal Concept]
   726 E C1300072:Stage [Clinical Attribute]

Phrase: "by neurodegenerescence"

Phrase: "and"

Phrase: "ultimately death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "27-30"

Phrase: ")."
Processing 00000000.tx.148: These pathologies became of higher interest when it appeared that some of these diseases could also affect human beings, leading to the logical suspicion that the human pathology could be transmitted by animals and, therefore, that mankind was facing a novel public health problem with unforeseeable consequences. 

Phrase: "These pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0030664:Pathologies [Biomedical Occupation or Discipline]
   966 E C0205469:pathology [Functional Concept]
   966 E C0677042:pathology [Pathologic Function]
   916 E C1521733:Pathologic [Functional Concept]

Phrase: "became of higher interest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0543488:Interest [Mental Process]
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "when"

Phrase: "it"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "some of these diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]

Phrase: "could"

Phrase: "also"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "human beings,"

Phrase: "leading to the logical suspicion"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0242114:Suspicion [Mental Process]
   760   C0332152:Leading [Temporal Concept]
   760   C1522538:Leading [Functional Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "the human pathology"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1512513:Human Pathology [Biomedical Occupation or Discipline]
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "transmitted by animals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0332289:Transmitted by [Functional Concept]
           transmitted
   790   C0003062:Animals [Animal]
   790   C0242781:Transmitted [Pathologic Function]
   790   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "that mankind"

Phrase: "was"

Phrase: "facing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015450:Face [Body Location or Region]
   966   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "a novel public health problem with unforeseeable consequences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033213:Problem [Finding]
Processing 00000000.tx.149: The boost of interest in this novel and intriguing type of pathology has been focused mainly on a better knowledge of a 33-35 kDa sialoglycosylated and glycosylphosphatidylinositol-anchored polypeptide called prion, which appears to be the main actor in the disease. 

Phrase: "The boost of interest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511253:Boost [Functional Concept]
   770   C1874596:BOOST [Food]

Phrase: "in this novel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205314:Novel [Temporal Concept]
  1000   C0679622:novel [Intellectual Product]

Phrase: "and"

Phrase: "intriguing type of pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "focused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205234:Focused [Spatial Concept]
  1000   C1285542:focused [Functional Concept]

Phrase: "mainly on a better knowledge of a 33-35 kDa sialoglycosylated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0332272:Better [Qualitative Concept]
   738   C0376554:Knowledge [Intellectual Product]
   738   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "glycosylphosphatidylinositol-anchored polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "prion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033164:Prion [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the main actor in the disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0335083:Actor [Professional or Occupational Group]
Processing 00000000.tx.150: Interestingly, it was demonstrated that the pathogenic agent (or at least clearly its main component) was a protein called scrapie, or PrPres, which has the same primary sequence as its ubiquitous counterpart, cellular prion or PrPc (1). 

Phrase: "Interestingly,"

Phrase: "it"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the pathogenic agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450442:Agent [Chemical Viewed Functionally]
   861   C1254351:Agent [Pharmacologic Substance]
   861   C1521826:Agent [Intellectual Product]

Phrase: "("

Phrase: "or at least clearly"

Phrase: "its main component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]

Phrase: ")"

Phrase: "was"

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "scrapie,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036457:Scrapie [Disease or Syndrome]

Phrase: "or"

Phrase: "PrPres,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074204:PrP-res [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "has"

Phrase: "the same primary sequence as its ubiquitous counterpart,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "cellular prion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033164:Prion [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.151: However, PrPres displays a -sheet-enriched structure that renders it highly resistant to proteolysis and prone to aggregation (1). 

Phrase: "However,"

Phrase: "PrPres"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074204:PrP-res [Amino Acid, Peptide, or Protein]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a -sheet-enriched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0359583:enriched [Food]

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "that"

Phrase: "renders"

Phrase: "it highly resistant to proteolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "prone to aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033422:Prone [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.152: How PrPres acquires its pathological conformation is not yet established but infectious inoculates "mimicking" the disease require endogenous PrPc to propagate, as they are fully innocuous in mice engineered to abrogate their endogenous PrPc protein content (6). 

Phrase: "How PrPres"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074204:PrP-res [Amino Acid, Peptide, or Protein]

Phrase: "acquires"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "its pathological conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "but"

Phrase: "infectious"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   928   C0009450:Infection, NOS [Disease or Syndrome]
   907 E C0030657:infectivity [Qualitative Concept]
   900 E C0439663:Infected [Functional Concept]

Phrase: "inoculates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987620:Inoculate [Therapeutic or Preventive Procedure]

Phrase: """mimicking"""

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "require"

Phrase: "endogenous PrPc to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   861   C1418941:PRION PROTEIN [Gene or Genome]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "propagate"

Phrase: ","

Phrase: "as"

Phrase: "they"

Phrase: "are"

Phrase: "fully innocuous in mice"

Phrase: "engineered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878517:engineered [Professional or Occupational Group]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "abrogate"

Phrase: "their endogenous PrPc protein content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C1555325:endogenous content [Intellectual Product]
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.153: Also yet not fully understood are the molecular determinants that initiate the pathogenic process in sporadic encephalopathies. 

Phrase: "Also yet"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: "are"

Phrase: "the molecular determinants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521761:Determinant [Functional Concept]

Phrase: "that"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "the pathogenic process in sporadic encephalopathies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.154: A better understanding of these sporadic cases would likely come from a better knowledge of the physiological function of PrPc and the putative dysfunction that takes place when these diseases occur. 

Phrase: "A better understanding of these sporadic cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162340:Understanding [Mental Process]

Phrase: "would"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "come from a better knowledge of the physiological function of PrPc"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   753   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   753   C1418941:PRION PROTEIN [Gene or Genome]
   751   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   751   C0815043:function protein [Amino Acid, Peptide, or Protein]
   751   C1527118:Protein Function [Molecular Function]
   736   C0031843:function [Physiologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205463:Physiological [Functional Concept]
   736   C0332272:Better [Qualitative Concept]
   736   C0376554:Knowledge [Intellectual Product]
   736   C0542341:Function [Functional Concept]
   736   C0700205:FUNCTION [Classification]
   736   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "the putative dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "that"

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "when"

Phrase: "these diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.155: Few things really are known concerning the physiological function of PrPc, but several lines of evidence indicate that PrPc could modulate cell death. 

Phrase: "Few things really"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1551338:Thing [Entity]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the physiological function of PrPc,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "but"

Phrase: "several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "indicate"

Phrase: "that PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: PrP mutations could trigger caspase activation (31), and murine scrapie appears to be associated with cell death (32). 

Phrase: "PrP mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "could"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "caspase activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1159825:Caspase Activation [Molecular Function]
   861   C1879547:Activation [Activity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "murine scrapie"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036457:Scrapie [Disease or Syndrome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with cell death"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   833   C0007587:Cell Death [Cell Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0699040:cell associated [Cell Component]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.157: Furthermore, prion infection impairs the cellular response to oxidative stress inducers (33) and triggers apoptosis in a hypothalamic neuronal cell line (34). 

Phrase: "Furthermore,"

Phrase: "prion infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0009450:Infection, NOS [Disease or Syndrome]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "impairs"

Phrase: "the cellular response to oxidative stress inducers"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   897   C2612716:cellular response to oxidative stress [Cell Function]
   853   C1155312:response to oxidative stress [Cell Function]
   840   C1516374:cellular response to stress [Cell Function]
           Cellular Stress Response
   804   C0149784:response to stress [Physiologic Function]
           response stress
   800   C1425942:CELLULAR STRESS RESPONSE [Gene or Genome]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "(33"

Phrase: ")"

Phrase: "and"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "apoptosis in a hypothalamic neuronal cell line"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C1660771:neuronal cell apoptosis [Cell Function]
           neuron apoptosis
   748   C0162638:Apoptosis [Cell Function]
   702 E C1836846:Apoptotic neurons [Finding]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.158: Altogether, these data suggest the ability of PrPc to modulate cell death, but whether this is due to an exacerbation of a proapoptotic function or, alternatively, to the alteration of an antiapoptotic phenotype could both be envisioned. 

Phrase: "Altogether,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the ability of PrPc to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "whether"

Phrase: "this"

Phrase: "is due to an exacerbation of a proapoptotic function"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]
   742   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: ","

Phrase: "alternatively,"

Phrase: "to the alteration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515926:Alteration [Idea or Concept]

Phrase: "of an antiapoptotic phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "could"

Phrase: "both"

Phrase: "be"

Phrase: "envisioned."
Processing 00000000.tx.159: The literature in this field does not really solve the debate, and there are opposing data supporting both possibilities. 

Phrase: "The literature in this field"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0023866:Literature [Intellectual Product]
   760   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "does"

Phrase: "not really"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "solve"

Phrase: "the debate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870392:debate [Activity]

Phrase: "and"

Phrase: "there"

Phrase: "are"

Phrase: "opposing data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "both possibilities."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   916   C0332149:Possible [Qualitative Concept]
   916   C1705910:Possible [Qualitative Concept]
   916   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.160: On one hand, Kuwahara et al. 

Phrase: "On one hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: "Kuwahara et al."
Processing 00000000.tx.161: (8) have shown that serum deprivation-induced cell death is exacerbated in hippocampal neurons prepared from Prnp-/- mice. 

Phrase: "(8"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that serum deprivation-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "exacerbated in hippocampal neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   770   C0027882:Neurons [Cell]
   770   C0436331:Exacerbated [Finding]
   770   C1444749:Exacerbated [Qualitative Concept]

Phrase: "prepared from Prnp-/- mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1418941:PRNP [Gene or Genome]
   737   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.162: On the other hand, PrPc also appears to protect human neurons from cell death triggered by overexpression of the proapoptotic oncogene Bax (9). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "PrPc also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect"

Phrase: "human neurons from cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2754100:neuron cell death [Cell Function]
           neuron death
   760   C0027882:Neurons [Cell]

Phrase: "triggered by overexpression of the proapoptotic oncogene Bax"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1444748:Triggered by [Qualitative Concept]
           Trigger
   744   C0029016:Oncogene [Gene or Genome]
   744   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0812198:BAX [Gene or Genome]
   744   C1514559:Overexpression [Genetic Function]
   711   C0032930:Trigger [Clinical Attribute]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.163: Finally, a recent paper indicates that PrPc could be a cellular mediator protecting retinal tissue from anisomycin-induced apoptosis (10). 

Phrase: "Finally,"

Phrase: "a recent paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030351:Paper [Manufactured Object]
   861   C1547566:Paper [Idea or Concept]

Phrase: "indicates"

Phrase: "that PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "be"

Phrase: "a cellular mediator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protecting"

Phrase: "retinal tissue from anisomycin-induced apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.164: From the above data one should expect a drastic deleterious effect of PrPc deletion due to the abrogation of this antiapoptotic phenotype. 

Phrase: "From the above data one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "should"

Phrase: "expect"

Phrase: "a drastic deleterious effect of PrPc deletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "due to the abrogation"

Phrase: "of this antiapoptotic phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.165: This seems not to be the case, as PrPc-deficient mice are safe, healthy, and apparently develop and behave normally (15). 

Phrase: "This"

Phrase: "seems"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "as"

Phrase: "PrPc-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "safe, healthy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0018684:Health [Idea or Concept]
   789   C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "develop"

Phrase: "and"

Phrase: "behave"

Phrase: "normally"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.166: Furthermore, a recent article indicates that post-natal deletion of the PrPc alters the excitability of CA1 hippocampal neurons but does not induce neurodegeneration in adulthood (12). 

Phrase: "Furthermore,"

Phrase: "a recent article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706852:Article [Intellectual Product]

Phrase: "indicates"

Phrase: "that post-natal deletion of the PrPc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the excitability of CA1 hippocampal neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0235169:Excitability [Sign or Symptom]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neurodegeneration in adulthood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.167: We had previously established that overexpression of PrPc enhances staurosporine-induced cell toxicity and DNA fragmentation and activates caspase-3 in stably transfected HEK293, TSM1 neurons, or inducible Rov9 cell lines (13, 14). 

Phrase: "We"

Phrase: "had"

Phrase: "previously"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that overexpression of PrPc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "staurosporine-induced cell toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   812   C0040539:toxicity [Qualitative Concept]
   812   C0600688:Toxicity [Injury or Poisoning]
   741 E C1407029:Toxic [Qualitative Concept]
   719 E C0032346:Poison [Hazardous or Poisonous Substance]
   719 E C1548769:Poison [Intellectual Product]
   719 E C1550590:poison [Idea or Concept]

Phrase: "and"

Phrase: "DNA fragmentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "and"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "caspase-3 in stably transfected HEK293,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "TSM1 neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "or"

Phrase: "inducible Rov9 cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.168: Furthermore, we showed that PrPc-induced caspase-3 activation is mediated by an Mdm2-regulated p53-dependent pathway in TSM1 neurons (14). 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PrPc-induced caspase-3 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   876   C0599177:protein activation [Genetic Function]
   839   C1159825:Caspase Activation [Molecular Function]
   799   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "mediated by an Mdm2-regulated p53-dependent pathway"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   767   C2984374:p53 pathway [Functional Concept]
   744   C0079419:P53 [Gene or Genome]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0812222:MDM2 [Gene or Genome]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C0851827:Dependent [Qualitative Concept]
   744   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1704259:Pathway [Molecular Function]
   744   C1705526:p53 [Gene or Genome]
   744   C1705987:Pathway [Conceptual Entity]
   744   C3244310:dependent [Functional Concept]

Phrase: "in TSM1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.169: These data are fully in agreement with a previous work demonstrating that transgenic mice overexpressing wild-type PrPc could exhibit severe neurodegeneration (11). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "fully in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with a previous work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "demonstrating"

Phrase: "that transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "wild-type PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   861   C1418941:PRION PROTEIN [Gene or Genome]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "severe neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.170: However, it could be argued that the PrPc-related phenotype could be, in both cases, due to overexpression of the protein. 

Phrase: "However,"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "argued"

Phrase: "that"

Phrase: "the PrPc-related phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031437:Phenotype [Organism Attribute]
   812   C1285572:Phenotype [Laboratory Procedure]

Phrase: "could"

Phrase: "be"

Phrase: ","

Phrase: "in both cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "due to overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of the protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.171: In line with such an hypothesis, a recent study nicely established that in N2A murine neuroblastoma cells, neurotoxicity and neurodegeneration could be associated with cytosolic accumulation of PrPc (35). 

Phrase: "In line with such"

Phrase: "an hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "a recent study nicely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that in N2A murine neuroblastoma cells,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   773   C0815000:neuroblastoma cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0026809:Murine [Mammal]
   753   C0027819:Neuroblastoma [Neoplastic Process]
   753   C0445079:N2a [Finding]
   753   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   753   C0700095:neuroblastoma [Neoplastic Process]
   753   C3282337:Cells [Cell]
   753   C3540583:Neuroblastoma [Intellectual Product]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "could"

Phrase: "be"

Phrase: "associated with cytosolic accumulation of PrPc"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1418941:PRION PROTEIN [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1383501:Cytosolic [Cell Component]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.172: These data fully agreed with our demonstration that the manipulation of cytosolic PrPc concentration could indeed affect cell death. 

Phrase: "These data fully"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "agreed with our demonstration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C3641827:Agree [Intellectual Product]

Phrase: "that"

Phrase: "the manipulation of cytosolic PrPc concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0185111:Manipulation, NOS [Therapeutic or Preventive Procedure]
   748   C0947647:Manipulation [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "indeed"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.173: Thus, proteasomal inhibition leads to increased PrPc-like immunoreactivity accompanied by drastic potentiation of caspase activation in HEK293 cells (13). 

Phrase: "Thus,"

Phrase: "proteasomal inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   964   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "leads to increased PrPc-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   806   C1418941:PRION PROTEIN [Gene or Genome]
   797   C0861064:increased lead [Finding]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0181586:leads [Medical Device]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "accompanied by drastic potentiation of caspase activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1159825:Caspase Activation [Molecular Function]
   748   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   748   C1879547:Activation [Activity]

Phrase: "in HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.174: Conversely, depletion of cellular PrPc by immunosequestration at the membrane precludes the PrPc-induced proapoptotic phenotype (13). 

Phrase: "Conversely,"

Phrase: "depletion of cellular PrPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333668:Depletion [Functional Concept]

Phrase: "by immunosequestration"

Phrase: "at the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "precludes"

Phrase: "the PrPc-induced proapoptotic phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031437:Phenotype [Organism Attribute]
   804   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.175: The present study first confirms that overexpression of PrPc enhances staurosporine-stimulated caspase-3 activity and demonstrates for the first time that in HEK293 cells, all PrPc-related phenotypes are p53-dependent. 

Phrase: "The present study first"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0150312:Present [Quantitative Concept]
   827   C0449450:Present [Idea or Concept]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that overexpression of PrPc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "staurosporine-stimulated caspase-3 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C1150132:caspase-3 activity [Molecular Function]
   853   C1150130:caspase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "demonstrates for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that in HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "all PrPc-related phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0031437:Phenotypes [Organism Attribute]
   779 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "are"

Phrase: "p53-dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
Processing 00000000.tx.176: These data have been fully reinforced by our observation that PrPc is inactive in p53-deficient fibroblasts. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "have"

Phrase: "been"

Phrase: "fully"

Phrase: "reinforced by our observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "inactive in p53-deficient fibroblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0225332:Inactive fibroblast [Cell]
   760   C0205254:Inactive [Qualitative Concept]
Processing 00000000.tx.177: Interestingly, we have established that, besides post-transcriptional modulation of p53, PrPc also enhances p53 promoter transactivation. 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that,"

Phrase: "besides post-transcriptional modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443264:Modulation [Spatial Concept]

Phrase: "of p53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "PrPc also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "p53 promoter transactivation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040624:Transactivation [Genetic Function]
Processing 00000000.tx.178: It was most important to establish that the p53-dependent PrPc-related phenotype was not solely due to an artifactual perturbation of the cell physiology caused by the overexpression of the protein. 

Phrase: "It"

Phrase: "was"

Phrase: "most important to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205393:Most [Quantitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that"

Phrase: "the p53-dependent PrPc-related phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031437:Phenotype [Organism Attribute]
   799   C1285572:Phenotype [Laboratory Procedure]

Phrase: "was"

Phrase: "not solely due to an artifactual perturbation of the cell physiology"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   756   C0007613:Cell physiology [Cell Function]
   756   C0678226:Due to [Functional Concept]
           due
   756   C1325880:cell physiology [Cell Function]
   738   C0007634:Cell [Cell]
   738   C0031842:Physiology [Biomedical Occupation or Discipline]
   738   C0031843:physiology [Physiologic Function]
   738   C0332453:perturbation [Functional Concept]
   738   C1269647:Cell [Cell]
   738   C1518422:Not [Functional Concept]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]
   738   C3146286:Due [Idea or Concept]

Phrase: "caused by the overexpression of the protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.179: In this context, we examined the contribution of endogenous PrPc to apoptotic response by monitoring cell death in primary cultured neurons derived from mice embryos in which the Prnp gene had been abrogated (Zrch-1). 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the contribution of endogenous PrPc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "to apoptotic response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "by monitoring cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "in primary cultured neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "derived from mice embryos"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0013935:Embryos [Embryonic Structure]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   737 E C1305370:Embryo [Embryonic Structure]

Phrase: "in which"

Phrase: "the Prnp gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418941:PRNP gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "had"

Phrase: "been"

Phrase: "abrogated"

Phrase: "(Zrch-1"

Phrase: ")."
Processing 00000000.tx.180: Our data show that deletion of PrPc led to a phenotype fully opposite of PrP overexpression. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that deletion of PrPc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "led to a phenotype"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0031437:Phenotype [Organism Attribute]
   770   C1285572:Phenotype [Laboratory Procedure]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "fully opposite of PrP overexpression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521805:Opposite [Spatial Concept]
Processing 00000000.tx.181: Prnp-/- neurons are indeed less sensitive to staurosporine as monitored by TUNEL-positive cells, DNA fragmentation, and caspase activity and immunoreactivity. 

Phrase: "Prnp-/- neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "indeed less sensitive to staurosporine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "as"

Phrase: "monitored by TUNEL-positive cells,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   806   C0439178:% positive cells [Quantitative Concept]
           % Positive
   760   C0007634:Cells [Cell]
   760   C0600528:TUNEL [Molecular Biology Research Technique]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726 E C1269647:Cell [Cell]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "DNA fragmentation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "and"

Phrase: "caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "immunoreactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.182: Furthermore, this phenotype appears linked to a drastic reduction of p53 activity and immunoreactivity. 

Phrase: "Furthermore,"

Phrase: "this phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "linked to a drastic reduction of p53 activity"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C2267000:Reduction Activity [Molecular Function]
   744   C0079419:P53 [Gene or Genome]
   744   C0205177:Activity [Functional Concept]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   744   C1705526:p53 [Gene or Genome]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "immunoreactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.183: Finally, the p53 activator (p38 MAPK) and inhibitor (Mdm2) immunoreactivities are reduced. 

Phrase: "Finally,"

Phrase: "the p53 activator"

Phrase: "(p38 MAPK)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Mdm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812222:MDM2 [Gene or Genome]
  1000   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "immunoreactivities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0597879:immunoreactivity [Molecular Function]

Phrase: "are"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.184: This indicates that PrPc likely controls p53, at least in part, at a post-transcriptional level, as we demonstrated in TSM1 neurons by an overexpression approach (13). 

Phrase: "This"

Phrase: "indicates"

Phrase: "that PrPc likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   901   C1418941:PRION PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "p53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "at a post-transcriptional level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "we"

Phrase: "demonstrated in TSM1 neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "by an overexpression approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.185: Therefore, our current study further demonstrates that PrPc controls caspase activity through a p53-dependent and Mdm2-regulated process and that this proapoptotic phenotype is not caused artifactually by overexpression of the protein. 

Phrase: "Therefore,"

Phrase: "our current study further"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "that PrPc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "caspase activity through a p53-dependent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1150130:caspase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Mdm2-regulated process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "that"

Phrase: "this proapoptotic phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "artifactually by overexpression of the protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.186: We recently established that in Alzheimer's disease, presenilin-2, a protein that when mutated mainly contributes to Alzheimer's disease-related pathologies, also controls cell death response to staurosporine by an identical p53-dependent mechanism (36). 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that in Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "presenilin-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "when"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "mainly"

Phrase: "contributes to Alzheimer's disease-related pathologies,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0030664:Pathologies [Biomedical Occupation or Discipline]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C1880177:Contribute [Activity]
   719 E C0205469:pathology [Functional Concept]
   719 E C0677042:pathology [Pathologic Function]

Phrase: "also"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cell death response to staurosporine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C3548732:response to staurosporine [Cell Function]
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "by an identical p53-dependent mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.187: This observation, together with our demonstration that similar proteolytic dysfunctions occur in both Alzheimer's and prion diseases, suggests that several common features could link apparently distinct neurodegenerative diseases (37). 

Phrase: "This observation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "together with our demonstration"

Phrase: "that similar proteolytic dysfunctions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0031847:dysfunction [Functional Concept]
   793   C0277785:Dysfunction, NOS [Qualitative Concept]
   755 E C0231174:Malfunction [Functional Concept]
   755 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "occur in both Alzheimer's"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "prion diseases,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0162534:Prion Diseases [Disease or Syndrome]
   966 E C3536911:Prion Disease [Pathologic Function]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0033164:Prion [Amino Acid, Peptide, or Protein]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that several common features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1521970:Feature [Qualitative Concept]
   793   C1706388:Feature [Conceptual Entity]
   793   C2346469:Feature [Qualitative Concept]
   793   C2348519:Feature [Qualitative Concept]

Phrase: "could"

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "apparently distinct neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   812   C0012634:Diseases [Disease or Syndrome]
   741 E C1836721:MALS [Finding]
   741 E C3538764:MALS [Gene or Genome]
   741 E C3540595:MAL [Gene or Genome]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.188: This is also true when one considers Parkinson's disease pathology in which an -synuclein anti-apoptotic physiological phenotype (22) is associated to p53 down-regulation, which is abolished by 60H-dopamine, a toxin associated with this pathology (38). 

Phrase: "This"

Phrase: "is"

Phrase: "also true"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205238:True [Qualitative Concept]

Phrase: "when"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "considers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "Parkinson's disease pathology in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]

Phrase: "an -synuclein anti-apoptotic physiological phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031437:Phenotype [Organism Attribute]
   804   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(22"

Phrase: ")"

Phrase: "is"

Phrase: "associated to p53 down-regulation,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0079419:P53 [Gene or Genome]
   760   C0332281:Associated [Qualitative Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   760   C1705526:p53 [Gene or Genome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "which"

Phrase: "is"

Phrase: "abolished by 60H-dopamine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   770   C1415602:60H [Gene or Genome]

Phrase: "a toxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "associated with this pathology"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.189: Altogether, these observations suggest envisioning p53 as a molecular target for therapeutic strategies in various neurodegenerative pathologies.  

Phrase: "Altogether,"

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "envisioning p53 as a molecular target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079419:P53 [Gene or Genome]
   753   C1705526:p53 [Gene or Genome]

Phrase: "for therapeutic strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategies [Mental Process]

Phrase: "in various neurodegenerative pathologies."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0030664:Pathologies [Biomedical Occupation or Discipline]
   793 E C0205469:pathology [Functional Concept]
   793 E C0677042:pathology [Pathologic Function]
   743 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.190: FOOTNOTES  * This work was supported by the CNRS, INSERM and by the Groupement d'Intrt Scientifique Infections  Prions. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the CNRS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "INSERM"

Phrase: "and by the Groupement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "d'"

Phrase: "Intrt Scientifique Infections  Prions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033164:Prions [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.191: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.192: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.193: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.194: These two authors contributed equally to this work. 

Phrase: "These two authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.195: || To whom correspondence should be addressed: Institut de Pharmacologie Molculaire et Cellulaire, UMR6097 du CNRS, 660 route des Lucioles, Sophia-Antipolis, 06560 Valbonne, France. 

Phrase: "||"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Institut de Pharmacologie Molculaire et Cellulaire,"

Phrase: "UMR6097 du CNRS,"

Phrase: "660 route des Lucioles,"

Phrase: "Sophia-Antipolis,"

Phrase: "06560 Valbonne,"

Phrase: "France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]
Processing 00000000.tx.196: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.197: 33-4-93-95-77-60; 

Phrase: "33-4-93-95-77-60"

Phrase: ";"
Processing 00000000.tx.198: Fax: 33-4-93-95-77-08; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "33-4-93-95-77-08"

Phrase: ";"
Processing 00000000.tx.199: E-mail: checler{at}ipmc.cnrs.fr . 1 The abbreviations used are: PrP, prion protein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "checler{at}ipmc.cnrs.fr . 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C2348513:Fr. [Conceptual Entity]
   799   C3538902:FR [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PrP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032027:PRP [Disease or Syndrome]

Phrase: "prion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
  1000   C1418941:PRION PROTEIN [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.200: TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling; 

Phrase: "TUNEL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600528:TUNEL [Molecular Biology Research Technique]

Phrase: "terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   918   C0872284:terminal deoxynucleotidyl transferase nick end labeling [Molecular Biology Research Technique]
   911   C0600528:terminal nick end labeling [Molecular Biology Research Technique]
   795   C1167624:Labeling [Mental Process]
   795   C1947902:Labeling [Manufactured Object]
   795   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: ";"
Processing 00000000.tx.201: HEK293 cells, human embryonic kidney cells; 

Phrase: "HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "human embryonic kidney cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.202: MAPK, mitogen-activated protein kinase.  

Phrase: "MAPK,"

Phrase: "mitogen-activated protein kinase."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.203: ACKNOWLEDGMENTS  We are most grateful to Pr. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "most grateful to Pr."
Processing 00000000.tx.204: Weissmann (Imperial College, London, UK) for providing Prnp-/- Zrch-1 mice. 

Phrase: "Weissmann"

Phrase: "(Imperial College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK"

Phrase: ")"

Phrase: "for providing Prnp-/- Zrch-1 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.205: PG13-luciferase-cDNA was generously provided by Dr. 

Phrase: "PG13-luciferase-cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "generously"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.206: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.207: Vogelstein (Howard Hughes Medical Institute, Baltimore). 

Phrase: "Vogelstein"

Phrase: "(Howard Hughes Medical Institute,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021622:institute [Organization]
   812   C0205476:Medical [Functional Concept]
   812   C1272753:Institute [Idea or Concept]
   812   C1551730:Hughes [Population Group]

Phrase: "Baltimore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: ")."
Processing 00000000.tx.208: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.209: Moshe Oren (Weizmann Institute of Science, Rehovot, Israel) for the kind gift of mouse p53 promoter-luciferase. 

Phrase: "Moshe Oren"

Phrase: "(Weizmann Institute of Science,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Rehovot,"

Phrase: "Israel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: ")"

Phrase: "for the kind gift"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0423899:Gifted [Finding]

Phrase: "of mouse p53 promoter-luciferase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.210: We are indebted to Drs Y. 

Phrase: "We"

Phrase: "are"

Phrase: "indebted to Drs Y."
Processing 00000000.tx.211: Frobert and J. 

Phrase: "Frobert"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.212: Grassi (CEA Saclay, France) for providing SAF32 monoclonals and to Dr. 

Phrase: "Grassi"

Phrase: "(CEA Saclay,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "for providing SAF32 monoclonals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0746619:monoclonal [Finding]

Phrase: "and to Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1515981:And [Idea or Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.213: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.214: Fahraeus for the gift of anti-Mdm2. 

Phrase: "Fahraeus for the gift of anti-Mdm2."
Processing 00000000.tx.215: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.216: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.217: Mattson (NIA, Baltimore) for providing us with pifithrin- and its inactive analog.  

Phrase: "Mattson"

Phrase: "(NIA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1074110:Nia [Fungus]
  1000   C1955974:NIA [Health Care Related Organization]

Phrase: "Baltimore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: ")"

Phrase: "for providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "us with pifithrin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0909264:pifithrin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "its inactive analog."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]
Processing 00000000.tx.218: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Prusiner, S. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.219: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.220: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.221: Natl. 

Phrase: "Natl."
Processing 00000000.tx.222: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.223: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.224: U. 

Phrase: "U."
Processing 00000000.tx.225: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.226: A. 

Phrase: "A."
Processing 00000000.tx.227: 95, 13363-13383[Abstract/Free FullText] Aguzzi, A., Montrasio, F., and Kaeser, P. 

Phrase: "95,"

Phrase: "13363-13383"

Phrase: "[Abstract/Free FullText"

Phrase: "] Aguzzi,"

Phrase: "A.,"

Phrase: "Montrasio,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Kaeser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.228: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.229: (2001) Nat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.230: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.231: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.232: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.233: 2, 118-126[CrossRef][Medline] [OrderarticleviaInfotrieve] Weissmann, C., Enari, M., Klhn, P.-C., Rossi, D., and Flechsig, E. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "118-126"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Weissmann,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Enari,"

Phrase: "M."

Phrase: ","

Phrase: "Klhn,"

Phrase: "P.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Rossi,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Flechsig,"

Phrase: "E."
Processing 00000000.tx.234: (2002) Acta Neurobiol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Acta Neurobiol."
Processing 00000000.tx.235: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.236: 62, 153-166[Medline] [OrderarticleviaInfotrieve] Prusiner, S. 

Phrase: "62,"

Phrase: "153-166"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.237: (1996) Trends Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.238: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.239: 21, 482-487[CrossRef][Medline] [OrderarticleviaInfotrieve] Ghetti, B., Piccardo, P., Frangione, B., Bugiani, O., Giaccone, G., Young, K., Prelli, F., Farlow, M. 

Phrase: "21,"

Phrase: "482-487"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ghetti,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Piccardo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bugiani,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Giaccone,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Prelli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.240: R., Dlouhy, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dlouhy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.241: R., and Tagliavni, F. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Tagliavni,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.242: (1996) Brain Pathol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Brain Pathol."
Processing 00000000.tx.243: 6, 127-145[Medline] [OrderarticleviaInfotrieve] Beler, H., Aguzzi, A., Sailer, A., Greiner, R., Autenried, P., Aguet, M., and Weissmann, C. 

Phrase: "6,"

Phrase: "127-145"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Beler,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Aguzzi,"

Phrase: "A.,"

Phrase: "Sailer,"

Phrase: "A.,"

Phrase: "Greiner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Autenried,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Aguet,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Weissmann,"

Phrase: "C."
Processing 00000000.tx.244: (1993) Cell 73, 1339-1347[CrossRef][Medline] [OrderarticleviaInfotrieve] Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., and Aguzzi, A. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cell 73,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1339-1347"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brandner,"

Phrase: "S."

Phrase: ","

Phrase: "Isenmann,"

Phrase: "S."

Phrase: ","

Phrase: "Raeber,"

Phrase: "A.,"

Phrase: "Fischer,"

Phrase: "M."

Phrase: ","

Phrase: "Sailer,"

Phrase: "A.,"

Phrase: "Kobayashi,"

Phrase: "Y.,"

Phrase: "Marino,"

Phrase: "S."

Phrase: ","

Phrase: "Weissmann,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Aguzzi,"

Phrase: "A."
Processing 00000000.tx.245: (1996) Nature 379, 339-343[CrossRef][Medline] [OrderarticleviaInfotrieve] Kuwahara, C., Takeuchi, A. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature 379,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "339-343"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kuwahara,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Takeuchi,"

Phrase: "A."
Processing 00000000.tx.246: M., Nishimura, T., Haraguchi, K., Kubosaki, A., Matsumoto, Y., Saeki, K., matsumoto, Y., Yokoyama, T., Itohara, S., and Onodera, T. 

Phrase: "M."

Phrase: ","

Phrase: "Nishimura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haraguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kubosaki,"

Phrase: "A.,"

Phrase: "Matsumoto,"

Phrase: "Y.,"

Phrase: "Saeki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "matsumoto,"

Phrase: "Y.,"

Phrase: "Yokoyama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Itohara,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Onodera,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.247: (1999) Nature 400, 225-226[CrossRef][Medline] [OrderarticleviaInfotrieve] Bounhar, Y., Zhang, Y., Goodyer, C. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 400,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "225-226"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bounhar,"

Phrase: "Y.,"

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Goodyer,"

Phrase: "C."
Processing 00000000.tx.248: G., and LeBlanc, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "LeBlanc,"

Phrase: "A."
Processing 00000000.tx.249: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.250: Biol. 

Phrase: "Biol."
Processing 00000000.tx.251: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.252: 276, 39145-39149[Abstract/Free FullText] Chiarini, L. 

Phrase: "276,"

Phrase: "39145-39149"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chiarini,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.253: B., Freitas, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Freitas,"

Phrase: "A."
Processing 00000000.tx.254: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.255: O., Zanata, S. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Zanata,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.256: M., Brentani, R. 

Phrase: "M."

Phrase: ","

Phrase: "Brentani,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.257: R., Martins, V. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Martins,"

Phrase: "V."
Processing 00000000.tx.258: R., and Linden, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Linden,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0771627:linden [Organic Chemical,Pharmacologic Substance]
  1000   C1024812:Linden [Plant]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.259: (2002) EMBO J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.260: 21, 3317-3326[Abstract/Free FullText] Westaway, D., DeArmond, S. 

Phrase: "21,"

Phrase: "3317-3326"

Phrase: "[Abstract/Free FullText"

Phrase: "] Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "DeArmond,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.261: J., Cayetano-Canlas, J., Groth, D., Foster, D., Yang, S.-L., Torchia, M., Carlson, G. 

Phrase: "J.,"

Phrase: "Cayetano-Canlas,"

Phrase: "J.,"

Phrase: "Groth,"

Phrase: "D."

Phrase: ","

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "D."

Phrase: ","

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "S.-L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Torchia,"

Phrase: "M."

Phrase: ","

Phrase: "Carlson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.262: A., and Prusiner, S. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.263: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.264: (1994) Cell 76, 117-129[CrossRef][Medline] [OrderarticleviaInfotrieve] Mallucci, G. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 76,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "117-129"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mallucci,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.265: R., Ratt, S., Asante, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ratt,"

Phrase: "S."

Phrase: ","

Phrase: "Asante,"

Phrase: "E."
Processing 00000000.tx.266: A., Linehan, J., Gowland, I., Jefferys, J. 

Phrase: "A.,"

Phrase: "Linehan,"

Phrase: "J.,"

Phrase: "Gowland,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jefferys,"

Phrase: "J."
Processing 00000000.tx.267: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.268: R., and Collinge, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Collinge,"

Phrase: "J."
Processing 00000000.tx.269: (2002) EMBO J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.270: 21, 202-210[Abstract/Free FullText] Paitel, E., Alves da Costa, C., Vilette, D., Grassi, J., and Checler, F. 

Phrase: "21,"

Phrase: "202-210"

Phrase: "[Abstract/Free FullText"

Phrase: "] Paitel,"

Phrase: "E.,"

Phrase: "Alves da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035561:Costa [Body Part, Organ, or Organ Component]
   734 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Vilette,"

Phrase: "D."

Phrase: ","

Phrase: "Grassi,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.271: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.272: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.273: 83, 1208-1214[CrossRef][Medline] [OrderarticleviaInfotrieve] Paitel, E., Fahraeus, R., and Checler, F. 

Phrase: "83,"

Phrase: "1208-1214"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Paitel,"

Phrase: "E.,"

Phrase: "Fahraeus,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.274: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.275: Biol. 

Phrase: "Biol."
Processing 00000000.tx.276: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.277: 278, 10061-10066[Abstract/Free FullText] Bueler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H., DeArmond, S., Prusiner, S. 

Phrase: "278,"

Phrase: "10061-10066"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bueler,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fischer,"

Phrase: "M."

Phrase: ","

Phrase: "Lang,"

Phrase: "Y.,"

Phrase: "Bluethmann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lipp,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "DeArmond,"

Phrase: "S."

Phrase: ","

Phrase: "Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.278: B., Aguet, M., and Weissmann, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Aguet,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Weissmann,"

Phrase: "C."
Processing 00000000.tx.279: (1992) Nature 356, 577-582[CrossRef][Medline] [OrderarticleviaInfotrieve] Vincent, B., Beaudet, A., Dauch, P., Vincent, J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 356,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "577-582"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Beaudet,"

Phrase: "A.,"

Phrase: "Dauch,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vincent,"

Phrase: "J."
Processing 00000000.tx.280: P., and Checler, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.281: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.282: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.283: 16, 5049-5059[Abstract/Free FullText] Macleod, K., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. 

Phrase: "16,"

Phrase: "5049-5059"

Phrase: "[Abstract/Free FullText"

Phrase: "] Macleod,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sherry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0452259:Sherry [Food]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hannon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "D."

Phrase: ","

Phrase: "Tokino,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kinzler,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vogelstein,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jacks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708586:Jack [Manufactured Object]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.284: (1995) Genes Dev. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.285: 15, 935-944 Donehower, L. 

Phrase: "15,"

Phrase: "935-944 Donehower,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.286: A., Harvey, M., Slagle, B., McArthur, M., Montgomery, C. 

Phrase: "A.,"

Phrase: "Harvey,"

Phrase: "M."

Phrase: ","

Phrase: "Slagle,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "McArthur,"

Phrase: "M."

Phrase: ","

Phrase: "Montgomery,"

Phrase: "C."
Processing 00000000.tx.287: A. 

Phrase: "A."
Processing 00000000.tx.288: J., Butel, J., and Bradley, A. 

Phrase: "J.,"

Phrase: "Butel,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Bradley,"

Phrase: "A."
Processing 00000000.tx.289: (1992) Nature 356, 215-221[CrossRef][Medline] [OrderarticleviaInfotrieve] Bradford, M. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 356,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "215-221"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bradford,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.290: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.291: (1976) Anal. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.292: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.293: 72, 248-259[CrossRef][Medline] [OrderarticleviaInfotrieve] Yin, Y., Luciani, M. 

Phrase: "72,"

Phrase: "248-259"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945618:yin [Idea or Concept]

Phrase: "Y.,"

Phrase: "Luciani,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.294: G., and Fahraeus, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Fahraeus,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.295: (2002) Nat. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.296: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.297: 4, 462-467[CrossRef][Medline] [OrderarticleviaInfotrieve] Demart, S., Fournier, J. 

Phrase: "4,"

Phrase: "462-467"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Demart,"

Phrase: "S."

Phrase: ","

Phrase: "Fournier,"

Phrase: "J."
Processing 00000000.tx.298: G., Cremignon, C., Frobert, Y., Lamoury, F., Marce, D., Lasmzas, C., Dormont, D., Grassi, J., and Deslys, J.-P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cremignon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Frobert,"

Phrase: "Y.,"

Phrase: "Lamoury,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Marce,"

Phrase: "D."

Phrase: ","

Phrase: "Lasmzas,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Dormont,"

Phrase: "D."

Phrase: ","

Phrase: "Grassi,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Deslys,"

Phrase: "J.-P."
Processing 00000000.tx.299: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.300: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.301: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.302: Commun. 

Phrase: "Commun."
Processing 00000000.tx.303: 265, 652-657[CrossRef][Medline] [OrderarticleviaInfotrieve] Alves da Costa, C., Ancolio, K., and Checler, F. 

Phrase: "265,"

Phrase: "652-657"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Alves da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035561:Costa [Body Part, Organ, or Organ Component]
   734 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.304: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.305: Biol. 

Phrase: "Biol."
Processing 00000000.tx.306: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.307: 275, 24065-24069[Abstract/Free FullText] El-Deiry, W., Kern, S., Pietenpol, J., Kinzler, K., and Vogelstein, B. 

Phrase: "275,"

Phrase: "24065-24069"

Phrase: "[Abstract/Free FullText"

Phrase: "] El-Deiry,"

Phrase: "W.,"

Phrase: "Kern,"

Phrase: "S."

Phrase: ","

Phrase: "Pietenpol,"

Phrase: "J.,"

Phrase: "Kinzler,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Vogelstein,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.308: (1992) Nat. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.309: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.310: 1, 45-49[CrossRef][Medline] [OrderarticleviaInfotrieve] Ginsberg, D., Oren, M., Yaniv, M., and Piette, J. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "45-49"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ginsberg,"

Phrase: "D."

Phrase: ","

Phrase: "Oren,"

Phrase: "M."

Phrase: ","

Phrase: "Yaniv,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Piette,"

Phrase: "J."
Processing 00000000.tx.311: (1990) Oncogene 5, 1285-1290[Medline] [OrderarticleviaInfotrieve] Bykov, V. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Oncogene 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "1285-1290"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bykov,"

Phrase: "V."
Processing 00000000.tx.312: J. 

Phrase: "J."
Processing 00000000.tx.313: N., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Wiman, K., and Selivanova, G. 

Phrase: "N., Issaeva,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shilov,"

Phrase: "A.,"

Phrase: "Hultcrantz,"

Phrase: "M."

Phrase: ","

Phrase: "Pugacheva,"

Phrase: "E.,"

Phrase: "Chumakov,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wiman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Selivanova,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.314: (2002) Nat. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.315: Med. 

Phrase: "Med."
Processing 00000000.tx.316: 8, 282-288[CrossRef][Medline] [OrderarticleviaInfotrieve] Zhu, Y., Mao, X. 

Phrase: "8,"

Phrase: "282-288"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhu,"

Phrase: "Y.,"

Phrase: "Mao,"

Phrase: "X."
Processing 00000000.tx.317: O., Sun, Y., Xia, Z., and Greenberg, D. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y.,"

Phrase: "Xia,"

Phrase: "Z.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "D."
Processing 00000000.tx.318: A. 

Phrase: "A."
Processing 00000000.tx.319: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.320: Biol. 

Phrase: "Biol."
Processing 00000000.tx.321: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.322: 277, 22909-22914[Abstract/Free FullText] Chesebro, B. 

Phrase: "277,"

Phrase: "22909-22914"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chesebro,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.323: (1999) Neuron 24, 503-506[CrossRef][Medline] [OrderarticleviaInfotrieve] Aguzzi, A. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuron 24,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "503-506"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Aguzzi,"

Phrase: "A."
Processing 00000000.tx.324: (2001) Nat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.325: Med. 

Phrase: "Med."
Processing 00000000.tx.326: 7, 289-290[CrossRef][Medline] [OrderarticleviaInfotrieve] Martins, V. 

Phrase: "7,"

Phrase: "289-290"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Martins,"

Phrase: "V."
Processing 00000000.tx.327: R., and Brentani, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Brentani,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.328: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.329: (2002) Neurochem. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.330: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.331: 1223, 1-3 Hur, K., Kim, J. 

Phrase: "1223,"

Phrase: "1-3 Hur,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1414371:HuR [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kim,"

Phrase: "J."
Processing 00000000.tx.332: I., Choi, S.-I., Choi, E.-K., Carp, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Choi,"

Phrase: "S.-I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Choi,"

Phrase: "E.-K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Carp,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007284:carp [Fish]
  1000   C0328038:Carp [Fish]
  1000   C0677526:Carp [Food]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.333: I., and Kim, Y.-S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Kim,"

Phrase: "Y.-S."
Processing 00000000.tx.334: (2002) Mech. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mech."
Processing 00000000.tx.335: Ageing Dev. 

Phrase: "Ageing Dev."
Processing 00000000.tx.336: 123, 1637-1647[CrossRef][Medline] [OrderarticleviaInfotrieve] Jamieson, E., Jeffrey, M., Ironside, J. 

Phrase: "123,"

Phrase: "1637-1647"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jamieson,"

Phrase: "E.,"

Phrase: "Jeffrey,"

Phrase: "M."

Phrase: ","

Phrase: "Ironside,"

Phrase: "J."
Processing 00000000.tx.337: W., and Fraser, J. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Fraser,"

Phrase: "J."
Processing 00000000.tx.338: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.339: (2001) NeuroReport 12, 3567-3572[CrossRef][Medline] [OrderarticleviaInfotrieve] Siso, S., Puig, B., Varea, R., Vidal, E., Acin, C., Prinz, M., Montrasio, F., Badiola, J., Aguzzi, A., Pumarola, M., and Ferrer, I. 

Phrase: "(2001"

Phrase: ")"

Phrase: "NeuroReport 12,"

Phrase: "3567-3572"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Siso,"

Phrase: "S."

Phrase: ","

Phrase: "Puig,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Varea,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vidal,"

Phrase: "E.,"

Phrase: "Acin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332260:ACIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Prinz,"

Phrase: "M."

Phrase: ","

Phrase: "Montrasio,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Badiola,"

Phrase: "J.,"

Phrase: "Aguzzi,"

Phrase: "A.,"

Phrase: "Pumarola,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ferrer,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.340: (2002) Acta Neuropathol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.341: 103, 615-626[CrossRef][Medline] [OrderarticleviaInfotrieve] Milhavet, O., and Lehmann, S. 

Phrase: "103,"

Phrase: "615-626"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Milhavet,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Lehmann,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.342: (2002) Brain Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.343: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.344: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.345: 38, 328-339[CrossRef][Medline] [OrderarticleviaInfotrieve] Schtzl, H. 

Phrase: "38,"

Phrase: "328-339"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schtzl,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.346: M., Laszlo, L., Holtzman, D. 

Phrase: "M."

Phrase: ","

Phrase: "Laszlo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.347: M., Tatzelt, J., DeArmond, S. 

Phrase: "M."

Phrase: ","

Phrase: "Tatzelt,"

Phrase: "J.,"

Phrase: "DeArmond,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.348: J., Weiner, R. 

Phrase: "J.,"

Phrase: "Weiner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.349: I., Mobley, W. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mobley,"

Phrase: "W."
Processing 00000000.tx.350: C., and Prusiner, S. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.351: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.352: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.353: Virol. 

Phrase: "Virol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]
Processing 00000000.tx.354: 71, 8821-8831[Abstract] Ma, J., Wollmann, R., and Lindquist, S. 

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "8821-8831"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ma,"

Phrase: "J.,"

Phrase: "Wollmann,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Lindquist,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.355: (2002) Science 298, 1781-1785[Abstract/Free FullText] Alves da Costa, C., Paitel, E., Mattson, M. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Science 298,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1781-1785"

Phrase: "[Abstract/Free FullText"

Phrase: "] Alves da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035561:Costa [Body Part, Organ, or Organ Component]
   734 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Paitel,"

Phrase: "E.,"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.356: P., Amson, R., Telerman, A., Ancolio, K., and Checler, F. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Amson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Telerman,"

Phrase: "A.,"

Phrase: "Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.357: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.358: Natl. 

Phrase: "Natl."
Processing 00000000.tx.359: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.360: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.361: U. 

Phrase: "U."
Processing 00000000.tx.362: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.363: A. 

Phrase: "A."
Processing 00000000.tx.364: 99, 4043-4048[Abstract/Free FullText] Checler, F., and Vincent, B. 

Phrase: "99,"

Phrase: "4043-4048"

Phrase: "[Abstract/Free FullText"

Phrase: "] Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Vincent,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.365: (2002) Trends Neurosci. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.366: 25, 616-620[CrossRef][Medline] [OrderarticleviaInfotrieve] Alves da Costa, C., Paitel, E., Vincent, B., and Checler, F. 

Phrase: "25,"

Phrase: "616-620"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Alves da Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035561:Costa [Body Part, Organ, or Organ Component]
   734 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Paitel,"

Phrase: "E.,"

Phrase: "Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.367: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.368: Biol. 

Phrase: "Biol."
Processing 00000000.tx.369: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.370: 277, 50980-50984[Abstract/Free FullText] This Article Abstract Full Text (PDF) All Versions of this Article: 279/1/612 most recent M310453200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Paitel, E. 

Phrase: "277,"

Phrase: "50980-50984"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "279/1/612 most recent M310453200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0441061:Shopping cart [Manufactured Object]
   788   C0179636:Cart [Manufactured Object]
   788   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Paitel,"

Phrase: "E."
Processing 00000000.tx.371: Articles by Checler, F. 

Phrase: "Articles by Checler,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.372: Articles citing this Article PubMed PubMed Citation Articles by Paitel, E. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Paitel,"

Phrase: "E."
Processing 00000000.tx.373: Articles by Checler, F. 

Phrase: "Articles by Checler,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.374: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2004 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2004 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

